Neovascular glaucoma

DM_NEOVASCULAR_GLAUCOMA

neovascular glaucoma: Neovascular glaucoma is the most common type of secondary glaucoma, usually caused by diabetic retinopathy, central retinal vein occlusion and carotid artery obstruction but sometimes by trauma, uvietis or ocular tumors, and characterized by severe eye pain, synechial angle glaucoma, high intraocular pressure and leading to loss of vision.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H40.5 Cause of death: ICD-10 — H40.5 2 out of 7 registries used, show all original rules.	1875
4. Check minimum number of events None	1875
5. Include endpoints None	1875
6. Filter based on genotype QC (FinnGen only)	1648

Control definitions (FinnGen only)

Control exclude: DM_RETINOPATHY

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H40
Name in latin: Glaucoma [secundarium] post aliam morbositatem oculi

NAME	DM_NEOVASCULAR_GLAUCOMA
CONTROL_EXCLUDE	DM_RETINOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H405
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H405
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Neovascular glaucoma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	13210	6427	6667
Only index persons	11515	5648	5867
Unadjusted period prevalence (%)
Whole population	0.18	0.18	0.19
Only index persons	0.22	0.21	0.22
Median age at first event (years)
Whole population	69.00	71.81	66.26
Only index persons	67.58	70.30	64.96

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1648	763	885
Unadjusted period prevalence (%)	0.34	0.27	0.41
Median age at first event (years)	65.25	62.28	67.81

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1717: Matched controls
17170

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XCW99

NOMESCO Finland

Other investigative procedure of eye

10.2

307.7

646

958

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

9.7

307.7

1317

4338

XCK00

NOMESCO Finland

Perimetry

13.0

307.7

501

527

H43.1

ICD-10 Finland

Vitreous haemorrhage

37.7

307.7

303

S01EC03

ATC

dorzolamide; ophthalmic

28.5

307.7

279

116

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

184.3

307.7

196

S01EE05

ATC

tafluprost; ophthalmic

15.9

307.7

386

308

H33.0

ICD-10 Finland

Retinal detachment with retinal break

22.0

307.7

317

175

S01EE03

ATC

bimatoprost; ophthalmic

19.5

307.7

298

183

S01EC01

ATC

acetazolamide; systemic

71.3

307.7

712

169

S01ED01

ATC

timolol; ophthalmic

31.4

307.7

658

333

114

Kela drug reimbursment

Glaucoma

41.0

307.7

1225

983

S01EE01

ATC

latanoprost; ophthalmic

25.3

307.7

859

653

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

+∞

307.7

1715

S01ED51

ATC

timolol, combinations; ophthalmic

82.9

307.7

1376

797

CKD40

NOMESCO Finland

Endophotocoagulation of retina

62.9

307.7

239

S01EC54

ATC

brinzolamide, combinations; ophthalmic

39.1

307.7

274

S01EC04

ATC

brinzolamide; ophthalmic

22.0

307.7

565

374

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

22.5

307.7

502

310

S01EA03

ATC

apraclonidine; ophthalmic

78.5

307.7

346

CKC20

NOMESCO Finland

Cryopexy of undetached retina

178.8

307.7

162

XCK10

NOMESCO Finland

Photography of fundus of eye

9.3

307.7

534

793

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

195.0

307.7

305

H20.1

ICD-10 Finland

Chronic iridocyclitis

96.3

307.7

377

WX140

NOMESCO Finland

Parabulbar anesthesy

25.4

307.7

579

337

H34.8

ICD-10 Finland

Other retinal vascular occlusions

27.8

307.7

300

130

H40.0

ICD-10 Finland

Glaucoma suspect

10.7

307.7

554

729

CKC12

NOMESCO Finland

Photocoagulation of retina

37.5

307.7

435

154

S01EA05

ATC

brimonidine; ophthalmic

68.2

307.7

765

200

Z96.1

ICD-10 Finland

Presence of intraocular lens

10.9

307.7

936

1701

H26.2

ICD-10 Finland

Complicated cataract

40.1

307.7

224

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

22.7

307.7

485

293

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

10.2

307.7

579

815

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

35.7

307.7

333

115

CKD20

NOMESCO Finland

Removal of vitreous body substitute

95.9

301.2

157

S01BA07

ATC

fluorometholone; ophthalmic

29.2

289.5

197

S01EX03, ,

ATC

15.6

289.5

266

200

S01EE04

ATC

travoprost; ophthalmic

19.1

289.5

237

143

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

9.8

288.5

376

476

Z01.0

ICD-10 Finland

Examination of eyes and vision

6.1

286.8

718

1811

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

35.2

281.8

180

XCH00

NOMESCO Finland

Eye pressure measurement

10.6

276.4

334

382

S01BC03

ATC

diclofenac; ophthalmic

18.5

275.7

229

142

CKC15

NOMESCO Finland

Panretinal photocoagulation

91.7

272.8

143

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

29.9

257.5

173

H40.9

ICD-10 Finland

Glaucoma, unspecified

16.2

257.1

229

162

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

5.2

239.9

1126

4628

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

5.3

236.9

1206

5265

A10AB01

ATC

insulin (human); parenteral

16.7

233.3

203

137

A10AA02, ,

ATC

15.4

230.7

210

154

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

8.4

225.9

328

468

A10AA01, ,

ATC

21.9

220.6

167

CKC10

NOMESCO Finland

Local photocoagulation of retina

25.9

218.2

154

S01BA04

ATC

prednisolone; ophthalmic

14.6

215.1

201

154

S01BA01

ATC

dexamethasone; ophthalmic

10.4

212.8

253

280

CJB10

NOMESCO Finland

Laser discission of secondary cataract

6.2

212.5

435

888

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

19.4

205.1

164

A10AC01

ATC

insulin (human); parenteral

7.2

202.4

343

578

S01FA04

ATC

cyclopentolate; ophthalmic

22.4

195.3

146

H40.8

ICD-10 Finland

Other glaucoma

49.4

190.7

111

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

10.1

178.9

215

240

H26.4

ICD-10 Finland

After-cataract

5.1

176.9

460

1148

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

82.8

176.9

H3603, E103,

ICD-10 Finland

1895.1

172.9

165

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

87.3

172.4

H21.0

ICD-10 Finland

Hyphaema

54.6

172.0

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

9.4

169.1

215

258

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

13.3

168.4

165

136

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

12.3

167.5

173

155

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

885.8

166.7

161

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

885.8

166.7

161

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

39.7

164.7

101

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

11.2

163.7

180

177

A10AB05

ATC

insulin aspart; parenteral

6.2

156.1

301

571

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

20.7

156.0

120

H3603, E113,

ICD-10 Finland

+∞

155.6

147

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

21.6

154.9

117

A10AE04

ATC

insulin glargine; parenteral

5.3

154.0

360

814

A10AB04

ATC

insulin lispro; parenteral

12.2

152.3

157

140

H16.0

ICD-10 Finland

Corneal ulcer

7.4

150.5

237

365

WX142

NOMESCO Finland

Sub-tenon anesthesy

31.7

146.9

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

16.9

141.6

120

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

24.0

141.4

102

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

47.8

140.0

H27.0

ICD-10 Finland

Aphakia

45.3

138.3

T89

ICPC

Diabetes insulin dependent

9.3

138.3

174

205

CHC05

NOMESCO Finland

Iridotomy

14.3

137.8

128

S01ED02

ATC

betaxolol; ophthalmic

17.3

137.4

115

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

16.1

136.9

119

CHD99

NOMESCO Finland

Other filtering operation

44.7

136.2

H54.4

ICD-10 Finland

Blindness, monocular

70.3

135.8

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

20.3

135.5

105

CHF15

NOMESCO Finland

Cryotherapy of ciliary body

1392.8

134.2

129

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

34.8

130.7

CKD15

NOMESCO Finland

Injection of vitreous substitute

163.9

130.4

136

H34.1

ICD-10 Finland

Central retinal artery occlusion

43.0

129.9

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

11.6

128.3

136

126

A10AE05

ATC

insulin detemir; parenteral

6.8

126.7

213

350

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

6.0

123.3

239

452

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

46.9

122.4

WX100

NOMESCO Finland

Conjunctival surface anesthesia

3.9

120.1

441

1395

H04AA01

ATC

glucagon; nasal, parenteral

17.0

119.9

101

S01EB01

ATC

pilocarpine; ophthalmic

18.9

119.0

A10AD01

ATC

insulin (human); parenteral

13.5

117.1

112

H18.1

ICD-10 Finland

Bullous keratopathy

56.3

114.7

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

6.9

113.9

187

299

H36.01

ICD-10 Finland

Diabetic maculopathy

306.6

113.5

114

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

43.5

112.0

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

1150.5

111.8

108

S01FA01

ATC

atropine; ophthalmic

24.7

109.6

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

14.0

109.1

102

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

33.1

108.7

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

30.0

108.4

XCD10

NOMESCO Finland

Electrophysiological examination of eye

8.9

107.8

139

168

ZXA05

NOMESCO Finland

Left side

3.1

107.6

660

2855

Z3229

NOMESCO Finland

Other healthcare associate professional

4.4

106.5

307

810

Z94.7

ICD-10 Finland

Corneal transplant status

36.1

105.1

TCG10

NOMESCO Finland

Removal of sutures from cornea

33.2

104.1

H25.1

ICD-10 Finland

Senile nuclear cataract

2.9

101.2

793

3900

ZXA00

NOMESCO Finland

Right side

3.0

99.1

687

3154

H3601, E113,

ICD-10 Finland

1014.9

99.1

H26.02

ICD-10 Finland

Presenil cataract

8.9

98.7

127

153

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

20.6

97.9

H40

ICD-10 Finland

Glaucoma

14.4

96.9

XCH05

NOMESCO Finland

Eye pressure longterm registration

16.2

95.4

XCD20

NOMESCO Finland

Photoangiography of eye

11.5

90.9

S01BC05

ATC

ketorolac; ophthalmic

5.4

90.4

191

388

E10

ICD-10 Finland

Type 1 diabetes mellitus

15.6

90.0

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

29.6

90.0

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

7.5

87.3

130

186

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

25.3

86.6

H3601, E103,

ICD-10 Finland

881.2

86.4

H26.3

ICD-10 Finland

Drug-induced cataract

19.9

86.2

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

41.2

85.7

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

6.9

85.1

136

210

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

17.9

84.6

CS494

NOMESCO Finland

Other visual field testing

7.3

82.6

126

185

103

Kela drug reimbursment

Diabetes, insulin-treated

2.7

78.8

637

3096

ZXA10

NOMESCO Finland

Bilateral

2.9

78.7

483

2036

S01EE51

ATC

latanoprost and netarsudil; ophthalmic

20.7

78.6

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

12.5

77.5

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

7.4

75.2

113

163

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.5

75.2

111

157

CKC60

NOMESCO Finland

Local buckling of sclera using implant

21.4

74.5

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

12.2

74.2

A10AE06

ATC

insulin degludec; parenteral

6.7

72.8

120

191

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

13.8

72.7

H3600, E103,

ICD-10 Finland

738.5

72.7

L04AX03

ATC

methotrexate; systemic

3.6

72.6

267

826

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

3.4

72.6

309

1050

XCW10

NOMESCO Finland

Assessment of vision

9.9

71.8

CKC30

NOMESCO Finland

Cryopexy of detached retina

21.8

71.1

H04.10

ICD-10 Finland

Dry eye syndrome

3.4

71.0

302

1025

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.4

70.9

148

296

H36.00

ICD-10 Finland

Diabetic background retinopathy

190.5

70.7

L04AB04

ATC

adalimumab; parenteral

8.2

69.4

120

H16.9

ICD-10 Finland

Keratitis, unspecified

9.2

68.7

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

15.5

68.5

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

15.0

68.4

S01FA02

ATC

scopolamine; ophthalmic

14.2

68.4

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

26.8

68.2

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

6.6

67.7

112

179

CKC70

NOMESCO Finland

Circular buckling of sclera

27.8

67.5

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

9.5

67.3

H40.3

ICD-10 Finland

Glaucoma secondary to eye trauma

145.8

66.4

CHD00

NOMESCO Finland

Laser trabeculoplasty

9.3

66.2

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.6

66.1

533

2550

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

7.0

65.4

102

153

H3600, E113,

ICD-10 Finland

662.6

65.3

A10AA03, ,

ATC

16.7

65.2

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

33.1

65.2

H30.2

ICD-10 Finland

Posterior cyclitis

30.7

63.7

L04AA01

ATC

[U] ciclosporin

11.8

63.2

WX002

NOMESCO Finland

Sedation and analgesia

2.6

61.7

455

2076

L04AA06

ATC

mycophenolic acid; systemic

8.4

60.6

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

110.7

59.2

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

26.2

59.0

TK800

NOMESCO Finland

Hemodialysis

6.9

58.5

139

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

12.6

56.6

127

Kela drug reimbursment

Transplant complication

9.3

56.6

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

15.7

56.4

Z94.0

ICD-10 Finland

Kidney transplant status

12.0

56.0

H27.1

ICD-10 Finland

Dislocation of lens

18.8

55.3

V03AE02

ATC

sevelamer; oral

22.1

55.3

H57.1

ICD-10 Finland

Ocular pain

5.0

54.9

124

265

V03AE01

ATC

polystyrene sulfonate; oral

8.2

54.8

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

22.7

54.5

CKD60

NOMESCO Finland

Anterior vitrectomy

11.1

54.1

NHQ40

NOMESCO Finland

Amputation of toe

7.4

54.1

113

ZXE10

NOMESCO Finland

More than one and less than three hours

2.2

54.0

730

4302

A11CC03

ATC

alfacalcidol; systemic

6.1

53.5

166

Z49.1

ICD-10 Finland

Extracorporeal dialysis

8.5

52.9

L01BA01

ATC

methotrexate; systemic

4.9

52.5

120

259

ZX198

NOMESCO Finland

Other local administration

11.3

52.1

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

6.3

51.1

146

S01AD03

ATC

aciclovir; ophthalmic

4.9

51.0

116

249

SPAT1262

SPAT

Handing over of treatment supplies

2.5

50.7

387

1777

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

17.8

49.0

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

17.0

48.0

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

4.2

47.7

133

336

Z3231

NOMESCO Finland

Registered nurse

2.2

47.3

567

3148

A12AA04

ATC

calcium carbonate; oral

7.3

47.2

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

10.1

46.4

H33.4

ICD-10 Finland

Traction detachment of retina

76.7

46.2

H20.8

ICD-10 Finland

Other iridocyclitis

16.6

46.2

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

5.8

45.9

155

CKD50

NOMESCO Finland

Endodiathermy of retina

161.0

45.0

177

Kela drug reimbursment

Insulin glargine 300 U / ml

7.7

44.3

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

15.5

43.5

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

57.2

42.6

H18.8

ICD-10 Finland

Other specified disorders of cornea

13.6

42.6

S01EA02

ATC

dipivefrine; ophthalmic

14.9

42.6

137

Kela drug reimbursment

Uraemia requiring dialysis

10.5

41.4

CS2P4

NOMESCO Finland

Optic nerve head imaging

9.0

41.2

H44.5

ICD-10 Finland

Degenerated conditions of globe

92.4

41.0

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.4

40.3

151

467

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

40.0

200

735

L04AD02

ATC

tacrolimus; systemic

9.6

39.9

B05DA

ATC

Isotonic solutions

11.6

39.7

S01AX11

ATC

[U] ofloxacin

4.0

39.3

116

305

CGG45

NOMESCO Finland

Full thickness transplantation of cornea using homograft

75.4

39.1

ZXE00

NOMESCO Finland

One hour or less

2.0

38.3

723

4662

CHD35

NOMESCO Finland

Laser goniopuncture

11.7

37.9

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

6.8

37.5

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

13.7

37.4

196

Kela drug reimbursment

Paricalcitol and cinacalcet

14.4

37.4

N18.8

ICD-10 Finland

Other chronic renal failure

4.7

36.7

193

CG2T4

NOMESCO Finland

Topography assessment of cornea

9.0

36.4

ZXD20

NOMESCO Finland

Day surgery

2.5

36.2

268

1198

CD2S4

NOMESCO Finland

Photography of eye

11.8

36.1

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.5

36.0

247

1066

H33.5

ICD-10 Finland

Other retinal detachments

10.8

35.8

A10AD05

ATC

insulin aspart; parenteral

5.7

35.7

121

ZXC20

NOMESCO Finland

Use of chemical agents

5.0

35.4

159

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

12.3

35.1

Z49.0

ICD-10 Finland

Preparatory care for dialysis

8.4

34.3

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.3

33.7

282

1329

Z49.2

ICD-10 Finland

Other dialysis

10.2

33.7

B05DB

ATC

Hypertonic solutions

11.5

33.6

B03XA02

ATC

darbepoetin alfa; parenteral

4.8

33.4

167

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

8.8

33.2

CG2X4

NOMESCO Finland

Optical coherence tomography (OCT) of cornea

10.8

33.2

H35.36

ICD-10 Finland

Macular cyst

10.8

33.2

ZXD05

NOMESCO Finland

Urgent procedure

1.9

33.1

586

3655

H54.1

ICD-10 Finland

Severe visual impairment, binocular

75.7

33.0

S97

ICPC

Chronic ulcer skin

2.9

32.9

171

640

H40.6

ICD-10 Finland

Glaucoma secondary to drugs

91.9

32.8

3641A

ICD-9 Finland

Disorders of iris and ciliary body, Chronic iridocyclitis

119.0

32.8

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

38.2

32.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

32.4

299

1467

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

+∞

32.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

31.8

903

6503

H33.3

ICD-10 Finland

Retinal breaks without detachment

4.2

31.8

216

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

37.2

31.6

SPAT1009

SPAT

Measurement of intraocular pressure

6.1

30.9

H25.2

ICD-10 Finland

Senile cataract, morgagnian type

10.5

30.7

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

7.0

30.6

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

4.6

30.5

163

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

30.3

683

4569

M45

ICD-10 Finland

Ankylosing spondylitis

4.9

29.8

142

L04AD01

ATC

ciclosporin; systemic

6.2

29.8

TCA15

NOMESCO Finland

Retrobulbar therapeutic injection into orbit

157.8

29.7

3626

FHL

Extracapsular cataract surgery and implantation of an artificial lens

5.1

29.5

124

H54.5

ICD-10 Finland

Severe visual impairment, monocular

9.9

29.5

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

8.4

29.2

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

40.9

29.0

C09AA02

ATC

enalapril; systemic

2.0

29.0

418

2417

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

67.2

29.0

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

105.2

28.7

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

26.6

28.4

H3603, E107,

ICD-10 Finland

+∞

28.2

H54.0

ICD-10 Finland

Blindness, binocular

43.3

27.8

3656X

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]

101.8

27.7

N18.0

ICD-10 Finland

End-stage renal disease

6.7

27.7

C03CA01

ATC

furosemide; systemic

1.8

27.7

682

4651

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.7

27.4

163

653

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

10.5

27.2

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.5

26.9

277

CA1ME

NOMESCO Finland

Ultrasound oculometry

7.9

26.8

C08CA01

ATC

amlodipine; oral

1.7

26.6

731

5129

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

6.9

26.4

H25.8

ICD-10 Finland

Other senile cataract

2.2

26.2

261

1313

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

6.6

26.1

F28

ICPC

Limited function/disability (F)

9.0

26.0

T90

ICPC

Diabetes non-insulin dependent

1.9

25.9

440

2672

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

25.9

161

659

CKD95

NOMESCO Finland

Extended combined vitectomy and lens procedure through pars plana

27.4

25.8

A10BB01

ATC

glibenclamide; oral

3.1

25.8

112

378

ZX120

NOMESCO Finland

Intravenous

2.4

25.8

197

887

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.7

25.8

150

594

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

3.6

25.7

256

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.8

25.7

140

536

3643

FHL

Vitrectomy through pars Plana

45.0

25.6

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

28.9

25.4

CFD10

NOMESCO Finland

Repair of conjunctiva

39.5

24.9

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

24.9

227

1102

SPAT1229

SPAT

Assessment of need for aid

2.4

24.8

178

779

L04AX01

ATC

azathioprine; systemic

3.4

24.7

278

3663A

ICD-9 Finland

Cataract secondary to ocular disorders

35.0

24.3

L88

ICPC

Rheumatoid/seropositive arthritis

3.4

24.3

276

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.2

23.8

315

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

5.1

23.8

100

H54.7

ICD-10 Finland

Unspecified visual loss

8.7

23.7

CDC00

NOMESCO Finland

Enucleation of eye

126.8

23.6

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.8

23.4

125

473

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

4.2

23.3

151

A07EC01

ATC

sulfasalazine; oral, rectal

2.5

23.2

158

674

S05.1

ICD-10 Finland

Contusion of eyeball and orbital tissues

5.5

23.1

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

23.1

348

2025

S05.0

ICD-10 Finland

Injury of conjunctiva and corneal abrasion without mention of foreign body

4.5

23.0

127

H3603, E109,

ICD-10 Finland

+∞

23.0

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

22.9

472

3025

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

30.5

22.8

J01FF01

ATC

clindamycin; systemic

1.8

22.6

463

2958

F93

ICPC

Glaucoma

7.6

22.5

37520

ICD-8 Finland

Glaucoma, Secondary

45.7

22.4

H35.6

ICD-10 Finland

Retinal haemorrhage

8.4

22.3

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

4.1

22.3

156

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

6.7

22.2

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

7.1

22.1

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

21.7

452

2896

CJF30

NOMESCO Finland

Reduction of dislocation of artificial lens

22.5

21.7

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

21.7

409

2546

S01EX

ATC

Other antiglaucoma preparations

222.7

21.6

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

116.5

21.6

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

21.6

609

4240

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

21.5

1100

8891

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

9.1

21.2

B03XA01

ATC

erythropoietin; parenteral

6.2

21.1

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

34.3

21.1

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

21.1

264

1439

C10AA01

ATC

simvastatin; oral

1.6

21.0

774

5753

H25.0

ICD-10 Finland

Senile incipient cataract

2.5

21.0

143

610

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

60.8

20.9

CJF00

NOMESCO Finland

Secondary implantation of artificial lens in anterior chamber

60.8

20.9

H3602, E103,

ICD-10 Finland

+∞

20.9

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

20.8

442

2843

F99

ICPC

Eye/adnexa disease other

6.9

20.8

CFW99

NOMESCO Finland

Other operation on conjunctiva

21.8

20.8

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

37.7

20.8

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

37.7

20.8

205

Kela drug reimbursment

Chronic hypertension

1.7

20.7

541

3684

3711

FHL

Cyclodiateria or cryocoagulation

212.5

20.6

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

7.9

20.4

H05BX01

ATC

cinacalcet; oral

7.9

20.4

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.5

20.4

134

562

NGQ20

NOMESCO Finland

Amputation of lower leg

7.0

20.4

A10AB06

ATC

insulin glulisine; parenteral

7.3

20.4

R4180

NOMESCO Finland

Podiatric therapy

5.2

20.1

H18.2

ICD-10 Finland

Other corneal oedema

27.4

20.0

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

7.1

20.0

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

58.2

19.9

OAB50, ,

SPAT

2.3

19.9

155

702

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

+∞

19.8

S01AA01

ATC

chloramphenicol; ophthalmic

2.8

19.8

103

385

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

6.4

19.3

Z5132

NOMESCO Finland

Nursing associate professional

8.0

19.2

BEF00, ,

SPAT

8.0

19.2

ZYC01

NOMESCO Finland

Remote contact by phone

2.6

19.1

116

469

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.6

19.0

100

H15.1

ICD-10 Finland

Episcleritis

5.0

18.8

C02AC05

ATC

moxonidine; oral

2.6

18.7

109

431

F38

ICPC

Eye, Other laboratory test NEC

4.3

18.6

114

36402

ICD-8 Finland

Iritis, Iridocyclitis, uveitis chronica

30.4

18.3

Z90.0

ICD-10 Finland

Acquired absence of part of head and neck

25.3

18.2

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

5.8

18.1

CJF45

NOMESCO Finland

Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy

33.3

18.0

3708

FHL

Trabeculectomy or equivalent

53.1

18.0

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.0

17.9

3610A

ICD-9 Finland

Retinal detachments and defects, Retinal detachment with retinal defect

13.9

17.8

H3602, E113,

ICD-10 Finland

+∞

17.7

3656F

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA POST UVEITIDEM]

+∞

17.7

CKD99

NOMESCO Finland

Other intraoclular operations on vitreous body and retina

96.1

17.6

CGG99

NOMESCO Finland

Other reconstructive operations on cornea and sclera

181.8

17.5

3719

FHL

Other measure in this category

181.8

17.5

H02AB06

ATC

prednisolone; systemic

1.6

17.5

798

6149

H34.2

ICD-10 Finland

Other retinal artery occlusions

13.3

17.5

H40.11

ICD-10 Finland

Low pressure glaucoma

3.6

17.3

162

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.2

17.1

213

B01AC04

ATC

clopidogrel; oral

1.7

17.0

331

2064

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

17.0

247

1410

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

13.4

17.0

3793A

ICD-9 Finland

Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]

22.1

16.9

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.8

16.9

H3603, E106,

ICD-10 Finland

+∞

16.7

3620B

ICD-9 Finland

Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]

+∞

16.7

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

12.8

16.7

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.6

16.6

157

L04AB06

ATC

golimumab; parenteral

7.4

16.5

H26.1

ICD-10 Finland

Traumatic cataract

12.3

16.3

S01KA02

ATC

hypromellose; ophthalmic

4.3

16.3

100

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

6.6

16.2

Z2221

NOMESCO Finland

Medical doctor

1.6

16.1

450

3083

F29

ICPC

Eye symptom/complaint other

2.0

16.0

183

962

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.9

16.0

281

Z97.0

ICD-10 Finland

Presence of artificial eye

48.0

16.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

16.0

270

1614

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

15.9

220

1235

CG2S4

NOMESCO Finland

Photography of cornea

12.4

15.9

H33.2

ICD-10 Finland

Serous retinal detachment

15.8

15.7

H17.8

ICD-10 Finland

Other corneal scars and opacities

15.8

15.7

3649

FHL

Other measure in this category

+∞

15.6

H22.1*D86.8

ICD-10 Finland

Iridocyclitis in sarcoidosis

85.9

15.6

WZC30

NOMESCO Finland

Teaching

1.8

15.5

276

1673

H44.0

ICD-10 Finland

Purulent endophthalmitis

22.3

15.5

E10.01

ICD-10 Finland

Insulin-dependent diabetes diabetic coma with hyperglycemia

161.4

15.5

PE1AT

NOMESCO Finland

Femoral artery PTA

4.5

15.4

2504B

ICD-9 Finland

Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]

38.4

15.4

H43.8

ICD-10 Finland

Other disorders of vitreous body

2.1

15.4

162

827

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

7.1

15.3

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

15.3

416

2827

CFB00

NOMESCO Finland

Suture of conjunctiva

28.9

15.2

A10BA02

ATC

metformin; oral

1.6

15.1

478

3366

37403

ICD-8 Finland

Cataract, Complicata

45.4

15.1

H40.19

ICD-10 Finland

Other primary glaucoma with open ventricular angle

15.2

14.9

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.3

14.9

110

487

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

6.0

14.8

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

57.2

14.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

14.7

487

3460

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

14.7

654

4959

H221, M084,

ICD-10 Finland

+∞

14.6

TCH12

NOMESCO Finland

Sample aspiration from anterior chambre

+∞

14.6

H01.0

ICD-10 Finland

Blepharitis

2.3

14.5

115

524

H43.3

ICD-10 Finland

Other vitreous opacities

4.6

14.5

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

6.6

14.5

CKD45

NOMESCO Finland

Endocryotherapy of retina

151.2

14.5

J01DB01

ATC

cefalexin; oral

1.6

14.4

1325

11660

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

12.7

14.4

S01FA06

ATC

tropicamide; ophthalmic

27.4

14.3

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

14.2

151

773

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.4

14.2

149

R4180, ,

SPAT

4.7

14.0

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.9

14.0

223

C08CA13

ATC

lercanidipine; oral

1.7

14.0

262

1610

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.2

13.9

176

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.5

13.9

351

3640A

ICD-9 Finland

Disorders of iris and ciliary body, Acute and subacute iridocyclitis

30.3

13.9

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.4

13.9

151

36400

ICD-8 Finland

Iritis, Iridocyclitis acuta

11.5

13.8

CJF15

NOMESCO Finland

Secondary implantation of skleral fixed artificial lens in posterior chamber

24.0

13.8

L04AA13

ATC

[U] leflunomide

3.4

13.7

152

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

13.7

454

3217

SPAT1263

SPAT

Sampling

1.5

13.6

651

4987

S18

ICPC

Laceration/cut

1.5

13.6

760

6008

N083, E102,

ICD-10 Finland

+∞

13.6

H35.29

ICD-10 Finland

Other proliferative retinopathy

+∞

13.6

CL2L4

NOMESCO Finland

Wide-field fundus photography for diabetic retinopathy screening

+∞

13.6

A46

ICD-10 Finland

Erysipelas

1.7

13.5

273

1711

T85.3

ICD-10 Finland

Mechanical complication of other ocular prosthetic devices, implants and grafts

141.1

13.5

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

13.4

1083

9187

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

18.4

13.4

Q12.0

ICD-10 Finland

Congenital cataract

26.0

13.4

S01BA09

ATC

clobetasone; ophthalmic

21.3

13.3

C10AX09

ATC

ezetimibe; oral

1.7

13.3

276

1742

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

13.3

199

1144

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

13.3

287

L28

ICPC

Limited function/disability (L)

1.6

13.3

356

2401

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

13.2

131

653

L04AA17

ATC

[U] adalimumab

13.9

13.2

AA1AD

NOMESCO Finland

CT of head and brain

1.5

13.2

523

3850

H44.2

ICD-10 Finland

Degenerative myopia

40.4

13.2

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

13.1

424

2985

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.4

13.1

137

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.7

13.0

278

WX213

NOMESCO Finland

Lower leg blockade

5.3

13.0

F43

ICPC

Eye, Other diagnostic procedure

3.6

13.0

123

CKA10

NOMESCO Finland

Biopsy of vitreous body

19.2

12.9

37872

ICD-8 Finland

Other diseases of eye, Aphakia artefacta, acquisita

19.2

12.9

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

50.4

12.8

E0000UV, ,

ATC

1.5

12.8

642

4949

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

14.2

12.8

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

12.7

319

2113

3651A

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]

9.7

12.7

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

12.7

289

1868

A10BH05

ATC

linagliptin; oral

2.3

12.6

101

463

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

6.0

12.6

Q15.0

ICD-10 Finland

Congenital glaucoma

70.4

12.6

74439

ICD-8 Finland

Congenital anomalies of eye, Cataracta NUD

70.4

12.6

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

12.6

112

536

H3603, H405,

ICD-10 Finland

+∞

12.5

JLE03

NOMESCO Finland

Allogenic total transplantation of pancreas with pancreaticoenterostomy

+∞

12.5

H18.6

ICD-10 Finland

Keratoconus

9.4

12.5

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

24.5

12.5

25008

ICD-8 Finland

Diabetes mellitus, Complicatio alia definita

24.5

12.5

CDC10

NOMESCO Finland

Enucleation of eye with insertion of prosthesis

130.9

12.4

CGG60

NOMESCO Finland

Reinforcement of sclera using graft

130.9

12.4

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.4

12.4

A02BC02

ATC

pantoprazole; systemic

1.5

12.4

1096

9388

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

12.3

108

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

37.8

12.2

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

37.8

12.2

C10AA05

ATC

atorvastatin; oral

1.5

12.2

696

5487

L84

ICD-10 Finland

Corns and callosities

2.6

12.2

264

H16.2

ICD-10 Finland

Keratoconjunctivitis

6.1

12.1

H40.12

ICD-10 Finland

Pigmentary glaucoma

12.5

12.1

Z2446

NOMESCO Finland

Social worker

2.1

12.1

118

585

CJF20

NOMESCO Finland

Removal of artificial lens

26.9

12.0

N02BE01

ATC

paracetamol; systemic, rectal

1.6

12.0

1452

13223

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

12.0

217

1317

H18.4

ICD-10 Finland

Corneal degeneration

8.7

12.0

S05.6

ICD-10 Finland

Penetrating wound of eyeball without foreign body

21.4

12.0

CHB15

NOMESCO Finland

Puncture of anterior chamber of eye with replacement of aqueous

21.4

12.0

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

9.3

12.0

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

4.6

11.9

3718X

ICD-9 Finland

Corneal opacity and other disorders of cornea, Other corneal disorders

47.0

11.9

I50.0

ICD-10 Finland

Congestive heart failure

1.8

11.9

173

985

H19.1

ICD-10 Finland

Herpesviral keratitis and keratoconjunctivitis

14.8

11.8

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

11.8

329

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.7

11.7

234

QDB10, ,

SPAT

2.9

11.7

195

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

11.7

553

4198

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.7

11.7

F01

ICPC

Eye pain

2.8

11.7

201

CHW99

NOMESCO Finland

Other operation on anterior chamber, anterior chamber angle, iris or ciliary body

30.2

11.6

3747

FHL

Combined ablation and vitreous surgery with coagulation

65.4

11.6

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

19.1

11.6

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.0

11.6

169

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

11.6

408

H221, M083,

ICD-10 Finland

+∞

11.5

CH2S4

NOMESCO Finland

Photography of iris

120.8

11.4

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

5.4

11.4

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

11.4

233

1464

V03AE03

ATC

lanthanum carbonate; oral

11.9

11.3

3792A

ICD-9 Finland

Other disorders of eye, Disorders of vitreous body

35.3

11.3

A10BB12

ATC

glimepiride; oral

2.0

11.3

133

707

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

11.2

343

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

12.8

11.1

RS221, ,

NOMESCO Finland

4.0

11.0

R3120

NOMESCO Finland

Training in mobility skills

9.3

11.0

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.7

11.0

225

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

10.9

579

4481

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

10.8

144

796

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

10.8

268

1765

A10AD04

ATC

insulin lispro; parenteral

15.6

10.8

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

8.3

10.8

S20

ICPC

Corn/callosity

3.1

10.8

144

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

10.8

107

535

CHD10

NOMESCO Finland

Trabeculectomy

28.2

10.7

CHB99

NOMESCO Finland

Other operation on anterior chamber and anterior chamber angle

28.2

10.7

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

10.7

547

4199

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.6

10.7

252

H44.4

ICD-10 Finland

Hypotony of eye

60.4

10.6

XCD00

NOMESCO Finland

Clinical examination of eye in general anaesthesia

60.4

10.6

M14.6

ICD-10 Finland

Neuropathic arthropathy

60.4

10.6

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.8

10.6

200

SPAT1301

SPAT

No procedures

1.5

10.6

494

3727

H18.5

ICD-10 Finland

Hereditary corneal dystrophies

4.4

10.5

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

10.5

471

3525

TK820

NOMESCO Finland

Peritoneal dialysis

9.2

10.5

W44

ICD-10 Finland

Foreign body entering into or through eye or natural orifice

3.6

10.5

N0830, E102,

ICD-10 Finland

110.7

10.4

H16.3

ICD-10 Finland

Interstitial and deep keratitis

110.7

10.4

H3603, E116,

ICD-10 Finland

+∞

10.4

H3601, E116,

ICD-10 Finland

+∞

10.4

H28.0

ICD-10 Finland

Diabetic cataract

+∞

10.4

P01BA02

ATC

hydroxychloroquine; oral

1.9

10.4

123

654

A28

ICPC

Limited function/disability NOS

1.5

10.4

349

2464

SPAT1260

SPAT

Consultation of another employee

1.6

10.4

271

1808

H17.9

ICD-10 Finland

Corneal scar and opacity, unspecified

16.1

10.3

H16.1

ICD-10 Finland

Other superficial keratitis without conjunctivitis

12.1

10.3

J01MA02

ATC

ciprofloxacin; systemic

1.4

10.3

637

5054

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

10.3

119

628

CJF10

NOMESCO Finland

Secondary implantation of artificial lens in posterior chamber

18.9

10.3

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

9.6

10.3

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

4.6

10.3

8720/3-C69.3

ICD-O-3

Malignant melanoma, NOS, of choroid

23.5

10.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

10.2

121

644

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

10.2

437

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

10.2

596

4682

L17

ICPC

Foot/toe symptom/complaint

1.5

10.2

460

3446

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

10.2

170

1009

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

4.4

10.1

L04AA11

ATC

[U] etanercept

11.4

10.1

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.4

10.0

104

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.9

10.0

118

627

E87.5

ICD-10 Finland

Hyperkalaemia

2.9

10.0

156

H02.4

ICD-10 Finland

Ptosis of eyelid

2.6

10.0

230

H34.9

ICD-10 Finland

Retinal vascular occlusion, unspecified

14.7

10.0

CWW99

NOMESCO Finland

Other reoperation on eye and adjacent structures

40.3

10.0

CF2S4

NOMESCO Finland

Photography of conjunctiva

40.3

10.0

F94

ICPC

Blindness

40.3

10.0

M65.3

ICD-10 Finland

Trigger finger

2.3

9.9

349

L04AB01

ATC

etanercept; parenteral

3.9

9.9

CGG31

NOMESCO Finland

Posterior corneal lamellar transplantation

12.3

9.9

XCC00

NOMESCO Finland

Investigative irrigation of lacrimal passages

3.8

9.8

N19

ICD-10 Finland

Unspecified kidney failure

2.2

9.8

384

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

9.8

233

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

9.7

150

869

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.8

9.7

154

900

4AA12, ,

NOMESCO Finland

13.4

9.7

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.4

9.6

1187

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

9.6

208

1325

M86.6

ICD-10 Finland

Other chronic osteomyelitis

11.4

9.6

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.1

9.5

128

CGF10

NOMESCO Finland

Suture of laceration of cornea

15.1

9.5

R11

ICD-10 Finland

Nausea and vomiting

1.8

9.5

148

860

CGF35

NOMESCO Finland

Repair of cornea using graft

100.6

9.4

N08.32

ICD-10 Finland

Glomerular disorders in diabetes mellitus kidney failure

100.6

9.4

C69.42

ICD-10 Finland

Malignant tumor of ciliary melanoma

+∞

9.4

H3603, E119,

ICD-10 Finland

+∞

9.4

H3603, H431,

ICD-10 Finland

+∞

9.4

H3603, E108,

ICD-10 Finland

+∞

9.4

H3603, E117,

ICD-10 Finland

+∞

9.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

9.4

356

2572

CKC65

NOMESCO Finland

Removal of buckling implant from sclera

21.8

9.4

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

8.1

9.3

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.9

9.3

110

585

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

9.3

187

1167

N03AX16

ATC

[U] pregabalin

1.5

9.2

347

2505

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.1

9.1

429

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

4.8

9.1

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.0

9.1

464

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.3

9.0

101

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.7

9.0

171

H17.1

ICD-10 Finland

Other central corneal opacity

10.1

9.0

S01FB01

ATC

phenylephrine; ophthalmic

36.9

9.0

RJ521, ,

NOMESCO Finland

36.9

9.0

36409

ICD-8 Finland

Iritis, Unspecified

36.9

9.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

8.9

483

3725

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

8.9

149

884

CHC00

NOMESCO Finland

Iridotomy

24.1

8.9

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

8.9

159

962

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

12.6

8.9

N03AX12

ATC

[U] gabapentin; oral

1.6

8.9

241

1620

TK810

NOMESCO Finland

Hemofiltration

6.8

8.8

C09BA02

ATC

enalapril and diuretics; systemic

1.8

8.8

141

826

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.6

8.8

185

1LA05, ,

NOMESCO Finland

8.6

8.8

CJE15

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in anterior chamber and iridectomy or iridotomy

4.0

8.8

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

10.8

8.8

C09AA05

ATC

ramipril; oral

1.4

8.7

430

3259

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

8.7

125

709

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

8.7

300

2123

CHC03

NOMESCO Finland

Laser iridoplasty

14.1

8.7

3744

FHL

Pericardial identification surgery with coagulation (includes epi- and intrascleral indications and eg Lincoff catheter)

14.1

8.7

H53.4

ICD-10 Finland

Visual field defects

2.8

8.7

152

H30.0

ICD-10 Finland

Focal chorioretinal inflammation

50.2

8.7

CGF45

NOMESCO Finland

Suture of laceration of sclera

50.2

8.7

ZZA00

NOMESCO Finland

Split skin graft

2.4

8.6

247

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.1

8.6

115

C09CA01

ATC

losartan; oral

1.4

8.6

411

3099

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

9.0

8.5

3604

FHL

Penetration of the cornea

27.7

8.5

CDC40

NOMESCO Finland

Evisceration of eye with insertion of prosthesis

27.7

8.5

CA1AD

NOMESCO Finland

Orbita CT

20.1

8.5

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.9

8.5

132

I25.2

ICD-10 Finland

Old myocardial infarction

1.8

8.4

138

814

C69.40

ICD-10 Finland

Malignant tumor of ciliary body without histology

90.5

8.4

H35.37

ICD-10 Finland

Macular holes

3.6

8.4

RD210, ,

NOMESCO Finland

3.2

8.4

101

SPAT1216

SPAT

Assessment of functional ability

1.5

8.4

274

1917

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

4.9

8.4

PAW37

NOMESCO Finland

Biopsy of temporal artery

4.7

8.4

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.9

8.4

133

H36.04

ICD-10 Finland

Severe diabetic ophthalmopathy

+∞

8.3

37100

ICD-8 Finland

Corneal opacity, Cicatrix (nubecula, macula, leucoma) cornea

+∞

8.3

CKD75

NOMESCO Finland

Retinotomy

+∞

8.3

L04AB05

ATC

certolizumab pegol; parenteral

10.8

8.3

B00.5

ICD-10 Finland

Herpesviral ocular disease

10.8

8.3

J01CF05

ATC

flucloxacillin; systemic

1.8

8.3

113

631

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

8.3

363

WX199

NOMESCO Finland

Other local analgesia

2.3

8.2

272

H16.8

ICD-10 Finland

Other keratitis

14.5

8.2

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

8.2

130

761

TCC30

NOMESCO Finland

Intubation of lacrimal canaliculus/duct

4.6

8.1

UJF32

NOMESCO Finland

Coloscopy

1.4

8.1

405

3072

WX144

NOMESCO Finland

Subconjunctival anesthesy

3.5

8.1

G63.2

ICD-10 Finland

Diabetic polyneuropathy

8.2

8.1

H30.1

ICD-10 Finland

Disseminated chorioretinal inflammation

33.5

8.1

CK2K4

NOMESCO Finland

Red-free imaging of ocular fundus

17.3

8.1

H44.1

ICD-10 Finland

Other endophthalmitis

17.3

8.1

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.0

8.1

456

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

8.1

320

N02AX02

ATC

tramadol; systemic, rectal

1.4

8.0

665

5475

RJ120, ,

NOMESCO Finland

22.1

8.0

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

3.6

8.0

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

8.0

336

2470

SPAT1310

SPAT

Counselling related to known health issue

1.4

7.9

450

3490

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.2

7.9

303

H40.1

ICD-10 Finland

Primary open-angle glaucoma

7.8

7.9

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

7.8

112

635

2500X

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,NUD]

8.5

7.8

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

8.5

7.8

C07AB02

ATC

metoprolol; systemic

1.4

7.8

351

2611

NHG20

NOMESCO Finland

Fusion of talocrural joint

7.0

7.8

ZZL00

NOMESCO Finland

Free graft of amniotic membrane

45.2

7.7

7433A

ICD-9 Finland

Congenital anomalies of eye, Congenital cataract and lens anomalies

45.2

7.7

H21.9

ICD-10 Finland

Disorder of iris and ciliary body, unspecified

45.2

7.7

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.5

7.7

C07AB07

ATC

bisoprolol; oral

1.3

7.6

818

6981

C69.3

ICD-10 Finland

Malignant neoplasm: Choroid

18.4

7.6

CCD60

NOMESCO Finland

Transnasal dacryocystorhinostomy

8.1

7.6

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

7.6

389

H22.0*B00.5

ICD-10 Finland

Herpesviral iridocyclitis

25.1

7.6

H22.1

ICD-10 Finland

Iridocyclitis in other diseases classified elsewhere

25.1

7.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

7.6

263

1862

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

8.9

7.5

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

3.3

7.5

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

7.5

102

569

C03DA01

ATC

spironolactone; oral

1.5

7.5

214

1452

PD4AD

NOMESCO Finland

CT of lower extremity arteries

4.3

7.5

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

7.1

7.5

H02AB04

ATC

methylprednisolone; systemic

1.5

7.5

212

1437

TNG10

NOMESCO Finland

Puncture of knee

3.7

7.5

J05AB01

ATC

aciclovir; systemic

1.4

7.5

314

2306

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.5

7.4

177

A10BX09

ATC

[U] dapagliflozin

4.4

7.4

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.4

7.4

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

4.4

7.4

N17.8

ICD-10 Finland

Other acute renal failure

3.2

7.4

N0832, E102,

ICD-10 Finland

80.4

7.4

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

7.4

122

721

SPAT1254

SPAT

Administration of medicine

1.5

7.4

243

1699

M01CB01

ATC

sodium aurothiomalate; parenteral

3.3

7.4

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

13.4

7.4

E11.01

ICD-10 Finland

Non-insulin dependent diabetes diabetic coma with hyperglycaemia

13.4

7.4

S01XA18

ATC

ciclosporin; ophthalmic

6.0

7.4

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

7.4

240

R42

ICD-10 Finland

Dizziness and giddiness

1.4

7.3

372

2825

Coronary artery bypass surgery

2.4

7.3

197

CGG20

NOMESCO Finland

Epikeratofakia or keratofakia

+∞

7.3

3624

FHL

Extracapsular soft cataract removal

+∞

7.3

CJB99

NOMESCO Finland

Other operation on lens for secondary cataract

+∞

7.3

H3601, E118,

ICD-10 Finland

+∞

7.3

CHB05

NOMESCO Finland

Puncture of anterior chamber of eye to lower intraocular pressure

+∞

7.3

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

9.4

7.3

TQW80

NOMESCO Finland

Local dermatologic skincare

2.5

7.3

179

3AC01, ,

NOMESCO Finland

3.9

7.3

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.8

7.3

546

SPAT1325

SPAT

Vaccination

1.4

7.2

511

4094

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

7.2

201

1358

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

7.2

424

3301

K08.3

ICD-10 Finland

Retained dental root

1.7

7.2

124

744

CJB30

NOMESCO Finland

Excision of secondary cataract

30.1

7.1

N18

ICPC

Paralysis/weakness

2.6

7.1

157

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

7.1

340

2554

N02AA05

ATC

oxycodone; systemic

1.4

7.1

323

2405

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

7.0

107

618

H15.0

ICD-10 Finland

Scleritis

8.8

7.0

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

10.1

7.0

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

7.0

379

2905

SPAT1151

SPAT

Treatment of major wounds

3.2

7.0

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.4

7.0

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

5.9

6.9

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.9

6.9

108

AN1

Coronary angiography

1.5

6.9

190

1279

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

6.9

540

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.9

6.9

489

S01BC01

ATC

indometacin; ophthalmic

13.8

6.9

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.1

6.9

327

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

6.9

161

1045

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

6.8

116

692

CJD20

NOMESCO Finland

Extracapsular cataract extraction with implantation of artificial lens in posterior chamber

8.3

6.8

RJ410, ,

NOMESCO Finland

8.3

6.8

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.6

6.8

143

XQ800

NOMESCO Finland

Prick test

1.9

6.8

470

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

6.8

463

2503B

ICD-9 Finland

Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]

40.2

6.8

CJF50

NOMESCO Finland

Removal and implantation of artificial lens in posterior chamber

40.2

6.8

C69.39

ICD-10 Finland

Malignant tumor in chorioidea other or unspecified histology

40.2

6.8

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.9

6.8

104

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

16.8

6.7

H05BX02

ATC

paricalcitol; systemic

16.8

6.7

R60.0

ICD-10 Finland

Localized oedema

1.5

6.7

200

1370

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

6.7

441

3487

K65.0

ICD-10 Finland

Acute peritonitis

3.4

6.7

NFQ20

NOMESCO Finland

Amputation of femur

3.3

6.7

S22

ICPC

Nail symptom/complaint

1.8

6.7

101

583

H40.29

ICD-10 Finland

Other [primary] glaucoma with closed ventricular angle

22.6

6.7

R4110

NOMESCO Finland

Physiotherapy

1.4

6.6

414

3247

S01GX08

ATC

ketotifen; ophthalmic

2.1

6.6

298

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.0

6.6

374

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

6.6

194

1325

A10BH02

ATC

vildagliptin; oral

2.6

6.6

140

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.8

6.6

117

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

10.1

6.5

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.3

6.5

214

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

6.5

189

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.8

6.5

506

A10BG02

ATC

rosiglitazone; oral

2.9

6.5

101

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

6.5

427

3025

Kela drug reimbursment

Calcium carbonate

5.7

6.5

NH3CG

NOMESCO Finland

Extensive MRI of foot

5.7

6.5

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

6.4

478

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

6.4

449

CBH30

NOMESCO Finland

Tarsorraphy

70.1

6.4

3656E

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA POSTTRAUMATICUM]

70.1

6.4

H360, E103,

ICD-10 Finland

70.1

6.4

H35.20

ICD-10 Finland

Proliferative vitreoretinopathy

70.1

6.4

CKD30

NOMESCO Finland

Internal drainage of subretinal fluid

70.1

6.4

Z89.4

ICD-10 Finland

Acquired absence of foot and ankle

70.1

6.4

N08.3

ICD-10 Finland

Glomerular disorders in diabetes mellitus

70.1

6.4

3768

FHL

Eye examination under general anesthesia

70.1

6.4

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

6.4

265

1936

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

14.4

6.4

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

6.4

201

1394

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

6.3

115

699

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

6.3

249

1803

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

6.3

508

4133

H66.9

ICD-10 Finland

Otitis media, unspecified

1.9

6.3

416

A12AA12

ATC

[U] calcium acetate

11.1

6.3

CJG15

NOMESCO Finland

Extraction of dislocated lens with implantation of artificial lens in anterior chamber and iridectomy or iridotomy

11.1

6.3

3651B

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]

9.3

6.3

J01DA01

ATC

[U] cefalexin

1.3

6.3

926

8165

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

6.3

147

954

S05.2

ICD-10 Finland

Ocular laceration and rupture with prolapse or loss of intraocular tissue

18.1

6.3

3654A

ICD-9 Finland

Glaucoma associated with congenital anomalies, dystrophies and systemic syndromes

+∞

6.3

3627A

ICD-9 Finland

Other retinal disorders, Hereditary retinal dystrophies[DYSTROPHIA RETINAE PIGMENTOSA]

+∞

6.3

37108

ICD-8 Finland

Corneal opacity, Alia definita

+∞

6.3

CWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in eye and adjacent structures

+∞

6.3

H3601, E117,

ICD-10 Finland

+∞

6.3

36399

ICD-8 Finland

Keratitis, Without mention of ulcer

+∞

6.3

CKD85

NOMESCO Finland

Removal of subretinal membrane or band

+∞

6.3

H3601, E107,

ICD-10 Finland

+∞

6.3

R55

ICD-10 Finland

Syncope and collapse

1.5

6.2

191

1316

3619

FHL

Other operations in this group, such as corneal refractive surgery

26.8

6.2

3642

FHL

Anterior vitrectomy

26.8

6.2

3656C

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA NEOVASCULARE]

26.8

6.2

WX402

NOMESCO Finland

General anaesthesia

1.4

6.2

291

2176

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

6.2

313

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

6.2

293

2194

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.2

6.2

239

NDG30

NOMESCO Finland

Fusion of wrist, total

5.8

6.1

A06AD11

ATC

lactulose; oral

1.4

6.1

265

1952

C07AB12

ATC

nebivolol; oral

2.2

6.1

214

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

6.1

299

2252

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

6.1

465

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

2.9

6.1

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

6.0

466

3793C

ICD-9 Finland

Other disorders of eye, Aphakia and other disorders of lens[PSEUDOPHAKIA]

6.7

6.0

L04AA24

ATC

abatacept; parenteral

6.7

6.0

RJ420, ,

NOMESCO Finland

6.7

6.0

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

6.0

249

1820

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.4

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

371

1738

2.45

46.08

2.7

1.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

267

1184

2.49

36.74

7.4

3.8

136.56

92.07

ng/l

4.61

232

1014

(3003458) Phosphate [Moles/volume] in Serum or Plasma

401

2132

2.15

35.92

13.7

5.6

1.15

1.03

mmol/l

9.17

375

1965

(3026250) Tacrolimus [Mass/volume] in Blood

8.57

35.70

52.5

37.7

7.34

6.76

ug/l

0.92

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

165

594

2.97

34.09

3.0

2.0

40.70

39.04

u/l

0.41

150

531

(3020779) Urea [Moles/volume] in Serum or Plasma

300

1447

2.30

33.99

16.6

7.0

13.48

10.65

mmol/l

7.82

290

1384

(40768446) Kidney Pathology biopsy report

9.95

33.95

1.8

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

148

5.03

33.23

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

924

6712

1.82

31.55

7.6

5.1

34.29

35.13

g/l

4.50

875

6270

(3012516) Albumin [Mass/volume] in Urine

695

4664

1.82

30.59

5.4

3.3

121.27

45.60

mg/l

4.58

518

3036

(3013115) Eosinophils [#/volume] in Blood

1003

7511

1.81

30.51

10.3

6.4

0.20

0.19

e9/l

0.19

916

6512

(3020682) Albumin/Creatinine [Ratio] in Urine

707

4779

1.81

30.30

6.4

3.9

22.79

8.07

mg/mmol

4.78

518

3027

(3006315) Basophils [#/volume] in Blood

979

7291

1.80

30.21

10.2

6.1

0.04

e9/l

0.11

899

6211

(3001604) Monocytes [#/volume] in Blood

976

7274

1.79

29.92

10.2

6.1

0.61

0.60

e9/l

0.97

896

6192

(3042936) Bacteria identified in Isolate by Culture

388

2174

2.01

29.51

3.2

2.0

—

(3019198) Lymphocytes [#/volume] in Blood

990

7427

1.79

29.49

10.2

6.2

1.72

1.90

e9/l

3.94

911

6481

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

404

2304

1.99

29.19

5.1

2.6

21.33

22.41

1.04

386

2137

(3004789) Transferrin [Mass/volume] in Serum or Plasma

426

2494

1.94

28.41

5.0

2.6

2.13

2.27

g/l

5.18

404

2290

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

289

3.54

28.07

3.2

2.3

191.11

102.23

ug/min

0.95

178

(3009508) Creatinine [Moles/volume] in Urine

711

4906

1.77

27.74

5.3

3.3

6.64

7.61

mmol/l

8.85

609

4136

(3022948) Iron [Moles/volume] in Serum or Plasma

442

2669

1.88

26.60

5.0

2.6

11.19

12.53

umol/l

4.39

421

2471

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

266

3.56

26.41

2.1

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

8.61

25.81

2.2

2.4

8.75

9.77

mg/l

0.28

(3013650) Neutrophils [#/volume] in Blood by Automated count

1051

8189

1.73

25.80

12.4

9.4

4.46

4.21

e9/l

2.37

955

7072

(3042733) HLA Ab [Presence] in Serum

9.27

25.66

6.0

3.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

488

3077

1.82

25.39

6.6

4.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

110

374

3.07

25.03

2.8

2.2

11.81

12.09

mg/l

0.12

110

344

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

271

3.45

24.96

2.0

1.4

—

19.88

—

(3035350) Ketones [Presence] in Urine by Test strip

986

7595

1.70

24.80

5.8

4.1

0.07

2.87

estimate

1.04

261

1664

(3021601) Nitrite [Presence] in Urine by Test strip

975

7491

1.70

24.73

5.8

4.1

0.00

estimate

0.50

254

1629

(3009261) Glucose [Presence] in Urine by Test strip

987

7626

1.69

24.34

5.9

4.1

4.41

0.20

estimate

0.47

229

1578

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

303

3.26

24.05

8.7

5.6

720.05

543.28

iu/ml

0.14

(3000850) Epithelial cells [#/volume] in Urine

537

3534

1.76

23.90

4.1

2.7

5.20

e6/l

0.00

499

3235

(3019069) Monocytes/Leukocytes in Blood

893

6762

1.67

23.41

10.3

6.5

8.86

8.99

0.82

862

6324

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

130

4.50

23.25

1.2

—

(3006504) Eosinophils/Leukocytes in Blood

890

6749

1.66

23.08

10.3

6.4

2.77

2.83

0.34

858

6307

(3022096) Basophils/Leukocytes in Blood

889

6746

1.66

22.94

10.4

6.4

0.66

0.67

0.18

858

6298

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.87

22.58

1.1

1.0

—

(3029937) Albumin [Presence] in Urine by Test strip

616

4266

1.69

22.49

6.1

4.1

0.00

0.01

estimate

1.34

212

1488

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

119

450

2.77

22.33

5.4

3.8

1.87

1.64

mg/l

2.00

113

405

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

171

772

2.35

22.17

2.2

1.8

1.57

1.53

g/l

0.19

150

669

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1299

10943

1.77

22.11

11.4

8.2

82.80

80.31

u/l

1.21

1243

10361

(3017143) Hepatitis C virus Ab [Presence] in Serum

263

1410

2.02

22.10

2.6

1.6

—

(3027945) Reticulocytes/Erythrocytes in Blood

333

1936

1.89

22.06

3.5

2.5

1.89

1.79

1.05

316

1721

(3012095) Magnesium [Moles/volume] in Serum or Plasma

412

2560

1.80

22.05

3.7

3.3

0.82

mmol/l

0.11

393

2416

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

237

3.45

22.04

2.1

1.4

174.59

160.05

au/ml

0.56

(3026008) Bacteria identified in Urine by Culture

666

4728

1.67

22.01

3.9

3.4

—

(3002030) Lymphocytes/Leukocytes in Blood

899

6892

1.64

21.87

10.4

6.4

25.41

26.72

2.99

875

6520

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

323

1865

1.90

21.84

4.2

4.3

250.00

248.51

u/l

0.06

312

1768

(3032080) INR in Blood by Coagulation assay

933

7221

1.64

21.83

19.6

17.8

1.30

1.33

inr

0.65

813

6080

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

138

4.24

21.56

2.3

2.4

28.30

49.48

iu/ml

—

(3018010) Neutrophils/Leukocytes in Blood

879

6754

1.62

20.77

10.2

6.3

59.49

58.05

3.14

859

6433

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

970

7637

1.62

20.70

13.7

7.2

1.20

1.21

mmol/l

1.88

846

6565

(42870588) Differential panel, method unspecified - Blood

684

4964

1.63

20.27

10.0

6.2

—

(3002179) Metamyelocytes/Leukocytes in Blood

236

1258

2.02

20.05

4.6

4.4

0.51

0.70

0.89

415

(3021589) Normoblasts [#/volume] in Blood

824

6272

1.60

19.95

19.2

11.8

0.00

e9/l

0.35

724

5105

(3013826) Glucose [Moles/volume] in Serum or Plasma

1072

8699

1.62

19.77

9.2

5.2

7.65

6.67

mmol/l

24.69

1045

8291

(3023520) Reticulocytes [#/volume] in Blood

265

1481

1.93

19.62

3.5

2.6

70.30

68.34

e9/l

0.43

212

1097

(3021440) Promyelocytes/Leukocytes in Blood

235

1261

2.00

19.57

4.9

4.6

0.12

0.00

378

(3023368) Bacteria identified in Blood by Culture

637

4577

1.62

19.45

6.2

4.4

—

(3025159) Blasts/Leukocytes in Blood

235

1264

2.00

19.44

5.2

4.8

0.54

0.15

0.42

348

(3017181) Myelocytes/Leukocytes in Blood

243

1328

1.97

19.19

4.8

4.5

0.66

0.90

1.01

446

(3021447) Carbon dioxide [Partial pressure] in Venous blood

290

1687

1.87

18.95

8.2

3.7

5.91

5.82

kpa

0.81

283

1646

(3015736) pH of Urine

796

6058

1.59

18.95

5.2

3.6

6.34

6.25

1.13

436

3389

(3018418) pH of Serum or Plasma

635

4585

1.61

18.86

9.8

4.1

7.39

7.40

3.09

502

3334

(3024471) HLA-A [Type]

8.17

18.79

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

109

431

2.63

18.74

1.6

1.5

0.57

17.14

iu/ml

0.48

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

782

5939

1.58

18.70

5.3

4.2

133.26

77.39

ng/l

0.33

624

4446

(3002032) Base excess in Venous blood by calculation

281

1632

1.86

18.42

9.5

3.7

1.21

1.94

mmol/l

3.60

252

1399

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

587

4180

1.61

18.34

3.0

2.3

3.11

2.89

mg/l

1.36

540

3569

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

823

6357

1.57

18.07

3.3

2.4

76.16

78.01

nmol/l

1.12

745

5683

(3003396) Base excess in Arterial blood by calculation

310

1870

1.80

17.93

7.5

0.37

0.96

mmol/l

1.31

244

1517

(3012544) pH of Venous blood

287

1694

1.83

17.83

8.2

3.7

7.37

7.38

2.70

206

1004

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

748

5667

1.57

17.79

5.8

4.1

0.50

0.42

estimate

0.05

212

1354

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

298

1791

1.80

17.41

2.4

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

239

1341

1.91

17.37

2.4

2.1

373.09

379.79

nmol/l

0.22

229

1242

(3028679) Herpes simplex virus Ab [Presence] in Serum

5.40

17.34

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

677

5037

1.57

17.30

5.0

3.5

167.71

87.33

e6/l

0.44

563

3918

(3016502) Oxygen saturation in Arterial blood

282

1672

1.82

17.22

7.8

7.9

94.99

95.33

0.38

273

1615

(3037467) Urinalysis macro (dipstick) panel - Urine

1168

9825

1.59

17.21

6.5

4.7

—

3.19

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

310

1893

1.78

17.15

7.6

7.5

5.01

5.09

kpa

0.76

298

1813

(3027801) Oxygen [Partial pressure] in Arterial blood

310

1894

1.78

17.11

7.6

7.5

11.82

11.90

kpa

0.09

297

1814

(3024354) Oxygen [Partial pressure] in Venous blood

249

1425

1.87

17.01

6.4

3.2

4.54

4.46

kpa

0.31

242

1391

(3019977) pH of Arterial blood

308

1885

1.77

16.89

7.7

7.6

7.40

7.42

1.79

194

1068

(3021879) Hepatitis B virus core Ab [Presence] in Serum

184

955

2.04

16.73

1.6

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

371

2399

1.70

16.69

2.7

2.1

29.67

29.74

0.05

366

2333

(3018095) Leukocytes [#/volume] in Urine

738

5637

1.54

16.55

6.0

4.1

147.40

116.87

e6/l

0.36

575

4085

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1215

10355

1.59

16.54

6.4

4.3

16.43

13.11

mm/h

8.82

1144

9623

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

148

3.66

16.51

1.2

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

235

3.06

16.31

3.6

3.2

256.29

1855.64

u/ml

—

(3030467) Casts [#/volume] in Urine by Automated count

592

4319

1.57

16.24

4.7

3.4

0.37

0.45

e6/l

0.46

480

3236

(3019309) Folate [Moles/volume] in Red Blood Cells

421

2832

1.64

16.22

1.9

1.8

1277.10

1163.30

nmol/l

1.66

343

2119

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

103

427

2.50

16.07

2.1

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

865

6877

1.52

15.87

13.1

6.5

1.21

mmol/l

0.50

812

6326

(3002173) Hemoglobin [Mass/volume] in Arterial blood

259

1533

1.81

15.82

8.5

8.4

115.82

120.70

g/l

3.21

254

1495

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

630

4689

1.54

15.67

3.5

3.3

36.02

33.08

u/l

0.26

599

4440

(3010375) cycloSPORINE [Mass/volume] in Blood

5.66

15.57

26.2

27.8

99.67

135.21

ug/l

1.90

(3035715) Granulocytes [#/volume] in Blood

254

2.91

15.39

3.9

3.3

4.71

4.42

e9/l

0.28

254

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

625

4660

1.54

15.34

4.5

2.6

68.98

78.81

u/l

0.22

584

4332

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

121

553

2.28

15.19

3.7

2.6

0.31

0.37

iu/ml

0.91

307

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

953

7786

1.50

14.99

6.5

11.48

12.08

umol/l

0.56

914

7433

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

654

4944

1.52

14.95

3.9

3.4

2867.59

1669.93

ng/l

3.85

571

4281

(3031040) Bacteria [#/volume] in Urine by Automated count

1126

9530

1.53

14.91

6.4

5.0

359.53

1457.10

e6/l

1.29

155

(3008898) HLA-B27 [Presence]

414

2.45

14.70

1.2

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

235

1380

1.81

14.68

2.3

2.7

66.92

66.39

g/l

0.46

218

1261

(3037522) Nuclear Ab [Titer] in Serum

291

1819

1.72

14.66

1.5

1.3

802.78

483.29

titre

1.12

389

(3020876) Protein [Mass/time] in 24 hour Urine

173

3.25

14.30

2.8

2.4

1.95

1.28

g/24h

0.65

103

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

6.23

14.21

3.3

4.5

11.44

8.35

mg/l

0.32

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

261

1596

1.75

14.19

4.0

3.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

622

4694

1.51

14.14

2.4

2.2

170.47

245.37

u/l

1.56

593

4452

(3000991) Gas panel - Venous blood

234

1390

1.79

14.04

13.2

8.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

10.14

13.97

1.1

1.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

147

751

2.05

13.92

5.6

3.2

24.55

25.21

mmol/l

1.27

142

727

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

254

2.79

13.66

1.5

1.2

264.17

269.75

u/ml

0.06

142

(3005719) IgG [Mass/volume] in Serum or Plasma

191

1077

1.87

13.56

2.9

11.56

10.78

g/l

0.67

176

985

(3026782) Osmolality of Urine

434

3068

1.55

13.19

4.1

3.0

505.08

536.75

mosm/kgh2o

2.64

391

2705

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.13

13.05

1.1

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

12.36

12.61

10.0

15.1

5.77

5.59

mmol/l

0.05

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

110

526

2.17

12.39

1.4

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

228

1392

1.74

12.39

2.7

2.5

6.98

7.03

ug/l

0.01

201

1215

(3028626) Oxygen [Partial pressure] in Capillary blood

428

2.29

12.36

3.7

3.8

8.31

8.06

kpa

0.72

419

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1478

13500

1.68

12.34

28.9

17.7

24.53

26.37

mg/l

1.39

1295

11353

(3011397) Hemoglobin [Presence] in Urine by Test strip

473

3465

1.50

12.01

6.1

3.9

0.40

0.08

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

659

5190

1.44

11.41

4.0

3.4

2.33

2.35

mmol/l

3.08

617

4689

(1616796) Gas panel - Central venous blood

353

2.36

11.39

6.0

4.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

189

1128

1.76

11.08

2.1

2.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

172

999

1.80

11.06

8.9

6.6

23.70

24.40

mmol/l

1.36

165

956

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

4.41

10.99

1.0

1.1

1957.63

1476.50

miu/ml

1.33

(40767503) Oxygen content in Capillary blood by calculation

322

2.39

10.91

3.3

2.6

15.69

16.04

0.38

316

(3028026) IgM [Mass/volume] in Serum or Plasma

152

854

1.86

10.88

1.8

1.57

1.44

g/l

0.22

136

782

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

435

3188

1.49

10.86

2.0

1.7

61308332.52

21969269.32

pmol/l

0.54

367

2631

(3035933) Granulocytes/Leukocytes in Blood

317

2.39

10.82

4.1

3.1

59.69

58.83

0.21

317

(46235355) HIV 1 and 2 tests - Meaningful Use set

310

2121

1.56

10.65

2.6

1.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

182

1090

1.75

10.54

5.1

4.0

5.04

5.16

kpa

1.14

175

1041

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

272

2.48

10.50

9.3

1.5

0.82

0.90

nmol/l

0.45

229

(3019550) Sodium [Moles/volume] in Serum or Plasma

1499

13871

1.64

10.33

34.3

21.2

139.27

139.60

mmol/l

4.58

1475

13588

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

187

1135

1.73

10.32

3.3

3.0

53.39

63.51

ml/min/173m2

3.00

500

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.85

10.23

1.9

2.9

570.80

1270.99

u/ml

1.36

(3004775) Volume in Urine collected for unspecified duration

3.60

10.22

3.3

2.2

692.00

646.54

0.19

(3014111) Lactate [Moles/volume] in Serum or Plasma

227

1458

1.64

10.12

9.5

7.6

1.35

1.36

mmol/l

0.06

222

1429

(3041096) Erythrocytes [Presence] in Urine by Automated

522

4009

1.43

10.08

4.6

3.6

0.26

0.05

estimate

0.38

195

1278

(3023103) Potassium [Moles/volume] in Serum or Plasma

1499

13893

1.62

10.00

35.1

21.4

4.02

3.99

mmol/l

2.63

1474

13589

(3017732) Neutrophils [#/volume] in Blood

259

1726

1.59

9.93

3.3

4.58

5.00

e9/l

0.35

232

1477

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

226

2.57

9.84

1.2

1.3

—

(3009343) pH of Capillary blood

176

1065

1.73

9.82

5.2

4.1

7.40

7.41

2.93

152

901

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1236

11038

1.43

9.67

33.9

21.7

13.94

13.76

4.68

1230

10885

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

277

2.40

9.64

1.4

1.2

—

(3024932) HLA-DR beta [Type]

7.18

9.51

1.1

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

417

3102

1.45

9.47

1.9

1.7

1.39

1.36

mg/l

0.08

347

2411

(3001122) Ferritin [Mass/volume] in Serum or Plasma

785

6526

1.37

9.33

4.8

3.1

160.29

139.78

ug/l

1.50

736

6013

(3000494) Fungus identified in Specimen by Culture

258

1742

1.57

9.32

1.7

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

384

2824

1.46

9.23

2.2

2.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.44

9.09

2.6

2.8

0.62

0.60

mmol/l

0.50

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

11.52

9.07

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

185

1163

1.66

8.95

2.0

1.7

—

(3021901) Oxygen saturation in Capillary blood

352

2.18

8.91

3.9

3.0

90.82

89.16

1.69

341

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

518

1.97

8.81

1.4

1.3

—

(3036489) Thrombin time

518

1.95

8.48

2.3

2.1

20.87

21.04

0.13

476

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

514

1.94

8.33

3.0

3.3

11.46

3.82

ratio

0.40

307

(3021960) Folate [Moles/volume] in Serum or Plasma

566

4530

1.37

8.25

1.9

1.7

20.88

19.77

nmol/l

0.72

496

3835

(3034860) Kappa light chains.free [Mass/volume] in Serum

104

568

1.88

8.16

2.9

3.5

87.85

58.55

mg/l

0.70

489

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

104

568

1.88

8.16

2.9

3.5

69.58

67.25

mg/l

0.03

490

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1524

14308

1.58

8.15

36.1

23.1

98.69

81.24

umol/l

14.99

1507

14109

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

169

1064

1.65

8.13

10.2

9.4

1.36

1.30

0.27

169

1055

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

792

6696

1.34

8.00

2.4

2.2

96.35

94.02

pmol/l

0.64

450

3633

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

402

2.04

7.99

1.7

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1179

0.46

7.95

2.2

2.0

3.20

3.50

ratio

1.67

944

(3014007) Fractional oxyhemoglobin in Arterial blood

166

1059

1.63

7.58

10.5

9.5

93.51

93.76

0.21

166

1051

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

152

949

1.66

7.55

4.9

3.9

1.23

1.88

mmol/l

0.84

100

693

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

278

1990

1.47

7.55

2.1

1.9

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

263

2.25

7.53

1.2

488.00

286.32

titre

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

412

1.99

7.48

1.5

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

392

2.01

7.44

1.5

1.3

—

(3045414) Leukocytes [Presence] in Urine

207

1402

1.54

7.32

2.3

2.1

0.00

0.02

estimate

0.78

275

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

291

2116

1.45

7.28

2.1

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

127

2.79

7.24

1.5

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

403

1.98

7.24

1.9

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

406

3141

1.38

7.13

3.3

3.0

2.46

mmol/l

0.59

366

2805

(3019150) Specific gravity of Urine by Refractometry

433

3386

1.37

7.12

6.6

4.2

1.02

kg/l

1.00

312

2283

(3026493) Urate [Moles/volume] in Serum or Plasma

484

3854

1.36

7.09

3.5

2.8

370.09

352.93

umol/l

2.39

418

3363

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

154

982

1.62

7.05

8.6

9.4

23.57

24.30

mmol/l

1.82

148

951

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

201

2.38

7.00

1.5

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.17

7.00

1.7

2.2

—

(40761536) Microorganisms panel - Urine sediment

177

1170

1.57

6.97

5.7

4.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

142

892

1.65

6.90

9.1

10.0

15.35

15.84

1.27

136

859

(3019832) Treponema pallidum Ab [Presence] in Serum

154

990

1.61

6.82

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.04

6.78

1.4

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

240

1704

1.47

6.77

13.7

7.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

296

2.10

6.73

1.4

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

310

2.07

6.70

1.8

1.4

174.14

679.73

e6/l

0.74

244

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

6.45

6.64

1.1

1.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1346

12460

1.37

6.61

6.2

5.2

1.97

1.98

mu/l

0.01

1245

11417

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1493

14078

1.46

6.51

18.7

12.2

25.37

25.80

u/l

0.40

1456

13660

(3007164) IgA [Mass/volume] in Serum or Plasma

348

2664

1.38

6.45

1.6

1.5

2.57

2.55

g/l

0.07

236

1611

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

181

1228

1.53

6.35

8.0

3.8

1.22

mmol/l

0.87

163

1052

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

345

1.98

6.32

1.4

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

116

708

1.68

6.31

2.0

1.9

3.24

2.39

ug/l

0.26

106

622

(3016750) Collection duration of Urine

3.27

6.28

3.7

2.2

499.63

505.29

min

0.13

(40758558) Short blood count panel - Blood

521

4264

1.32

6.19

8.2

6.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

385

1.91

6.09

2.7

2.2

123.41

127.59

g/l

0.60

304

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

862

0.45

6.08

1.8

3.30

3.46

mmol/l

0.40

629

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

275

2.07

6.02

1.5

1.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

233

1682

1.45

6.01

2.9

2.8

7.08

8.94

umol/l

0.86

196

1486

(3028433) Virus identified in Specimen by Culture

3.89

5.99

1.2

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.92

5.90

1.4

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

307

1.99

5.78

1.8

1.3

31.39

56.37

e6/l

0.34

234

(21494815) CD4 cells/Lymphocytes in Specimen

108

2.71

5.77

1.4

2.0

38.66

39.02

0.05

108

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1357

12656

1.34

5.75

10.0

6.4

44.95

39.25

mmol/mol

39.67

1259

11750

(3043409) Potassium [Moles/volume] in Arterial blood

444

1.82

5.75

6.8

4.0

4.04

3.92

mmol/l

1.18

438

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

116

727

1.64

5.72

4.3

4.7

1.51

1.55

0.24

109

685

(3012501) Base excess in Blood by calculation

316

1.96

5.68

7.0

5.0

2.54

2.65

mmol/l

0.12

220

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1143

10421

1.29

5.67

5.0

4.2

15.17

14.91

pmol/l

2.53

1033

9481

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

331

1.94

5.64

1.2

1.3

139.19

236.48

miu/ml

0.75

149

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

7.54

5.63

1.0

2.2

—

(21494755) Public health laboratory ask at order entry panel

968

0.50

5.61

1.3

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

297

1.99

5.59

1.4

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

405

1.84

5.54

1.5

1.6

—

(21494814) CD8 cells/Lymphocytes in Specimen

3.64

5.48

1.5

1.9

29.41

32.30

0.31

(3007461) Platelets [#/volume] in Blood

1528

14557

1.45

5.47

42.9

26.6

249.28

244.42

e9/l

1.99

1506

14241

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1528

14558

1.45

5.46

42.7

26.5

91.75

91.42

1.96

1513

14373

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

124

800

1.59

5.45

1.3

1.4

57.80

50.26

au/ml

—

(3026361) Erythrocytes [#/volume] in Blood

1528

14561

1.45

5.42

42.8

26.6

4.34

4.44

e12/l

11.02

1498

14199

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1528

14561

1.45

5.42

43.8

27.1

39.15

40.29

2.99

1514

14367

(3035941) MCH [Entitic mass]

1528

14561

1.45

5.42

42.7

26.5

30.37

30.40

0.25

1513

14373

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

205

1474

1.44

5.40

2.2

2.3

0.19

0.21

g/l

1.51

192

1366

(3010813) Leukocytes [#/volume] in Blood

1528

14564

1.45

5.38

42.9

26.6

7.02

6.86

e9/l

1.94

1501

14197

(3027135) IgG subclass 1 [Mass/volume] in Serum

124

2.53

5.38

1.5

1.3

6.66

6.82

g/l

0.08

(3000963) Hemoglobin [Mass/volume] in Blood

1528

14565

1.45

5.37

43.2

26.8

130.51

133.98

g/l

13.67

1516

14380

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

168

2.29

5.32

1.5

1.8

—

2306.67

—

(40761511) CBC panel - Blood by Automated count

1455

13759

1.38

5.30

25.9

15.9

—

(3000012) Reticulocyte production index

243

2.05

5.18

2.1

0.95

0.87

0.55

176

(3047181) Lactate [Moles/volume] in Blood

459

1.76

5.17

4.8

5.8

1.22

1.39

mmol/l

1.32

402

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

132

878

1.55

5.10

2.4

2.5

48.36

19.42

au/ml

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

315

1.90

5.07

1.9

2.2

3133.97

5159.89

u/l

0.28

128

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

247

2.01

4.97

1.4

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

124

2.44

4.89

1.5

1.3

2.77

2.81

g/l

0.04

(3024139) IgG subclass 3 [Mass/volume] in Serum

124

2.44

4.89

1.5

1.3

0.39

0.41

g/l

0.11

(3023420) DNA double strand Ab [Units/volume] in Serum

529

1.68

4.86

1.9

1.8

3.70

6.65

iu/ml

1.10

121

(3000570) Elastase.pancreatic [Mass/mass] in Stool

438

1.74

4.84

1.5

251.56

285.19

ug/g

0.69

264

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

761

6692

1.25

4.76

3.8

2.9

—

estimate

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

190

2.13

4.75

1.2

1.3

2.95

4.76

u/ml

0.34

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.43

4.75

3.5

3.1

5.08

4.80

kpa

0.65

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.43

4.75

3.5

3.1

10.47

10.44

kpa

0.01

(3011648) Oxygen content in Venous blood

158

2.24

4.70

3.3

4.4

10.94

10.48

0.29

158

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

337

2687

1.32

4.67

4.0

3.1

0.90

1.06

e6/l

0.47

197

1455

(4195642) Thrombophilia screening test

165

2.21

4.67

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

165

2.21

4.67

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

185

2.13

4.65

1.2

1.3

2.12

6.16

u/ml

1.84

(3014051) Protein [Presence] in Urine by Test strip

468

3898

1.28

4.65

4.0

3.2

0.13

0.04

0.27

114

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

103

2.55

4.64

1.4

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

8.22

4.56

1.2

2.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

493

1.67

4.53

1.4

1.2

0.35

1.19

u/ml

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1365

12863

1.30

4.52

27.4

17.2

72.70

77.53

ml/min/173m2

10.46

1304

11976

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

572

1.62

4.49

2.6

2.7

—

(3045424) Erythrocytes [Presence] in Urine

108

710

1.56

4.42

2.4

2.2

0.00

1.21

estimate

0.50

207

(3007930) Methemoglobin/Hemoglobin.total in Blood

102

663

1.57

4.39

4.8

4.9

0.82

0.87

0.53

624

(4062490) Immunoglobulin typing, IgG

125

2.34

4.35

1.6

1.3

—

(3017569) Oxygen content in Arterial blood

2.55

4.30

1.8

2.5

15.40

16.11

0.46

(3024980) IgG subclass 4 [Mass/volume] in Serum

212

2.01

4.28

1.5

1.6

0.42

0.84

g/l

2.95

170

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

8.92

4.28

1.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

356

1.77

4.28

1.3

1.6

—

(3025941) Bacteria identified in Stool by Culture

109

726

1.54

4.22

1.5

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

365

2988

1.28

4.11

1.5

1.3

1.17

1.40

u/ml

0.27

118

790

(3036525) Urea [Moles/time] in 24 hour Urine

10.03

4.01

4.0

6.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

163

2.11

3.99

2.1

2.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.58

3.97

1.2

82.10

95.00

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

188

1410

1.37

3.91

4.4

2.4

42.90

72.63

u/l

0.40

154

1191

(3028308) Erythrocytes [#/volume] in Pleural fluid

186

2.01

3.84

1.4

16014.85

94451.76

e6/l

1.32

109

(3023199) Leukocytes [#/volume] in Pleural fluid

214

1.94

3.84

1.3

1.4

1398.35

1531.59

e6/l

0.10

152

(3044290) Cell count panel - Cerebral spinal fluid

279

1.82

3.82

1.9

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

208

1.95

3.79

1.4

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

363

3000

1.27

3.76

5.0

4.2

211.86

370.13

ng/l

0.96

312

2472

(3047189) Immunofixation for 24 hour Urine

2.55

3.63

1.7

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

2.46

3.55

1.2

1.1

36.91

37.49

mg/l

0.03

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

124

2.20

3.55

1.1

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

10.03

3.50

2.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.63

3.49

1.1

1.9

71.31

98.50

nmol/24h

0.45

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.63

3.47

1.2

1.1

1.07

1.16

u/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

174

1.97

3.40

1.3

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.46

3.38

1.8

2.3

483.14

610.89

e6/l

0.50

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

344

1.68

3.36

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

109

770

1.44

3.23

4.1

3.5

4.35

4.49

pmol/l

0.73

101

682

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.35

3.22

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

334

1.67

3.19

1.9

2.9

31.14

33.96

umol/l

0.29

292

(3025549) Creatine [Moles/time] in 24 hour Urine

6.38

3.18

1.3

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

2.90

3.02

1.1

—

18.00

—

(3004451) EKG impression Narrative

107

2.17

2.97

1.4

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

141

2.00

2.96

2.5

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1389

13305

1.23

2.87

6.9

5.8

2.41

2.62

mmol/l

16.51

1291

12249

(3044640) Blood type and Crossmatch panel - Blood

545

4817

1.19

2.87

3.5

2.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

384

1.58

2.86

1.2

93.33

105.56

titre

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

417

1.56

2.83

1.5

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

116

851

1.39

2.81

1.8

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

110

2.11

2.79

2.2

1.1

106.91

107.05

pmol/l

0.00

110

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.59

2.78

70.1

7.6

7.64

5.34

kpa

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.21

2.74

3.5

1.7

106.05

94.67

ng/l

0.42

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.02

2.73

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

160

1.89

2.72

1.7

1.3

—

nmol/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.01

2.69

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

319

1.62

2.68

1.3

1.4

53.38

61.36

mmol/l

0.82

259

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

421

3656

1.20

2.67

3.5

2.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

490

1.49

2.63

2.7

2.4

0.00

g/l

-0.00

429

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.35

2.60

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.74

2.55

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.74

2.55

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.74

2.55

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.74

2.55

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.47

2.54

1.3

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

203

1641

1.27

2.53

2.5

2.4

186.07

129.57

ug/g

0.72

156

1323

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

603

1.43

2.52

2.5

2.4

11.35

10.64

g/l

0.51

536

(3044242) Glucose [Moles/volume] in Arterial blood

108

2.05

2.52

1.5

2.3

9.36

7.77

mmol/l

0.83

108

(3003329) Lymphocytes/Leukocytes in Synovial fluid

129

1.95

2.51

1.4

1.5

43.67

27.68

0.76

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1361

13060

1.20

2.50

6.1

5.1

4.27

4.52

mmol/l

15.22

1264

12093

(3039443) Prostate specific Ag panel - Serum or Plasma

255

0.39

2.46

1.2

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.10

2.43

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

174

1.80

2.43

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

344

1.56

2.42

2.0

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1351

12968

1.20

2.40

6.0

5.0

1.39

1.44

mmol/l

3.13

1248

11909

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

160

1.83

2.40

5.9

2.7

—

(3018572) Chloride [Moles/volume] in Blood

313

1.58

2.40

6.0

6.7

104.18

105.29

mmol/l

0.95

281

(3039000) Anion gap in Blood by calculation

313

1.58

2.40

6.0

6.7

11.57

11.35

mmol/l

0.18

281

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

354

1.54

2.37

2.5

1.9

2.95

21.29

iu/l

0.53

133

(3042631) Mycobacterium sp identified in Specimen

221

1.69

2.35

2.3

2.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

166

1323

1.28

2.33

3.2

307.55

235.81

ng/l

0.87

153

1216

(3035637) Corticotropin [Mass/volume] in Plasma

169

1.79

2.33

1.2

1.6

19.50

32.31

ng/l

1.07

169

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

683

1.38

2.29

2.4

2.3

7.69

7.38

g/l

1.15

620

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

683

1.38

2.29

2.4

2.3

3.88

3.69

g/l

0.41

619

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

683

1.38

2.29

2.4

2.3

4.17

4.18

g/l

0.07

621

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

223

1.67

2.28

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

354

0.50

2.28

1.6

1.1

0.51

0.65

ratio

—

(3000093) Morphology [Interpretation] in Blood Narrative

141

1.86

2.28

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

171

1.77

2.25

1.5

1.6

39.20

63.77

2.13

109

(4027681) Cerebrospinal fluid IgG ratio and IgG index

2.28

2.24

1.5

1.2

0.52

0.49

ratio

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

434

1.47

2.21

1.5

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

501

1.44

2.20

2.7

2.4

0.00

0.02

g/l

1.07

448

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

293

2505

1.20

2.18

4.3

3.2

2.05

2.21

e6/l

0.12

152

1274

(3037121) Protein [Mass/volume] in Urine

553

1.41

2.17

4.0

3.5

631.14

371.36

mg/l

0.63

232

(3001019) Free T4 and TSH panel - Serum or Plasma

512

0.60

2.17

1.6

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

589

1.39

2.13

2.7

2.5

1.40

1.24

g/l

0.08

505

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.11

2.13

1.1

1.0

—

(40768797) Stomach Pathology biopsy report

234

1964

1.22

2.11

1.3

—

(3026480) Teichoate Ab [Titer] in Serum

5.01

2.07

1.0

1.2

—

(4146454) Self-monitoring of blood glucose

146

1.79

2.07

3.8

2.4

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1155

11018

1.15

1.94

36.5

22.9

330.75

331.97

g/l

4.18

1147

10942

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

740

1.33

1.92

2.7

2.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

636

1.35

1.91

2.5

2.4

3.13

2.98

g/l

0.69

573

(3050129) First trimester maternal screen panel - Serum or Plasma

238

0.46

1.87

1.4

1.5

—

(44806420) Estimation of glomerular filtration rate

129

1.79

1.86

2.0

2.4

—

(3012441) Differential panel - Pleural fluid

182

1.66

1.85

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1290

12419

1.16

1.85

5.2

4.3

1.32

1.28

mmol/l

1.20

1178

11297

(3016650) Hepatitis A virus Ab [Presence] in Serum

215

1.59

1.80

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.77

1.79

2.6

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.77

1.79

1.0

1.1

—

(3022313) Gas panel - Capillary blood

758

1.31

1.78

5.7

4.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

398

1.42

1.73

1.7

1.6

7625.23

17801.30

e6/l

1.84

281

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

595

1.34

1.73

6.1

4.5

23.44

24.88

mmol/l

3.13

548

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.14

1.71

1.2

272.88

227.04

iu/ml

0.14

(4268621) Lupus anticoagulant assay

133

1.74

1.70

2.2

2.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

2.01

1.69

1.9

—

37.27

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.17

1.66

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

277

1.49

1.65

1.2

36.05

40.60

u/ml

—

(1761482) Bacteria [#/volume] in Urine by Culture

378

1.41

1.62

5.0

4.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.96

1.59

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

121

1.74

1.58

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.01

1.58

1.2

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

386

0.62

1.58

1.5

1.2

1.52

1.53

g/l

0.07

386

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.21

1.57

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.43

1.54

1.0

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

130

1.70

1.53

1.6

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

169

1.61

1.52

3.6

4.8

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.08

1.49

1.2

—

(3002619) Bacteria identified in Specimen by Culture

2.44

1.48

1.0

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

585

1.31

1.47

2.1

1.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

318

1.43

1.47

3.8

32.43

28.34

mg/l

0.27

227

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

366

0.62

1.46

1.4

1.6

869.22

984.48

mu/l

0.37

308

(3027944) Amphetamines [Presence] in Urine

390

0.64

1.46

3.2

1.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.73

1.43

1.0

1.5

—

(3017704) Immunofixation for Urine

1.80

1.43

1.2

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

111

1.72

1.39

4.8

5.8

231.63

59.96

u/ml

—

(3052851) Hemolysis interference index of Serum or Plasma

426

1.35

1.36

3.6

3.7

4.26

1.66

index

0.74

229

(3005322) IgE [Units/volume] in Serum or Plasma

105

853

1.25

1.35

1.3

146.32

235.98

u/ml

0.68

100

790

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

290

1.42

1.35

1.4

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

283

1.42

1.32

1.3

21.39

40.48

u/l

1.31

244

(3049717) Cytology report of Urine Cyto stain

667

1.27

1.31

2.6

2.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

817

7740

1.11

1.30

2.9

2.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

634

1.27

1.28

2.3

2.0

—

(3022145) Colonoscopy Study observation

181

1561

1.18

1.28

1.3

—

(40768806) Pleura Pathology biopsy report

178

1.53

1.26

1.5

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

146

1.58

1.26

1.7

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

131

1.61

1.23

1.0

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

2.05

1.22

1.1

1.5

2.48

3.46

mmol/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.64

1.21

1.2

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

436

1.32

1.20

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

385

1.33

1.17

1.3

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

938

8981

1.10

1.16

3.7

3.3

55.33

50.82

u/l

0.67

872

8398

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.06

1.15

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

391

0.69

1.15

3.1

1.9

—

(3023410) Appearance of Cerebral spinal fluid

142

1.56

1.14

3.0

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.69

1.14

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.69

1.14

1.2

—

(3016879) Cocaine [Presence] in Urine

366

0.68

1.13

3.2

1.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

388

1.32

1.12

1.3

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

266

2387

1.14

1.12

1.4

1.3

49.50

31.93

iu/ml

0.61

730

(3036782) Glucose [Moles/volume] in Pleural fluid

184

1.47

1.11

1.3

1.4

7.11

6.17

mmol/l

0.87

174

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

104

1.64

1.09

3.1

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

151

1743

0.85

1.09

6.1

4.9

32.66

32.85

0.07

1132

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

356

1.33

1.08

1.3

1.2

1.59

2.64

u/ml

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.66

1.06

1.6

1.4

—

(3018333) Ribosomal P Ab [Presence] in Serum

1.66

1.06

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

105

1.63

1.06

1.2

1.1

—

(21494434) Karyotype in Bone marrow

145

1.52

1.06

1.0

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1331

12988

1.11

1.05

5.9

5.2

6.65

5.96

mmol/l

23.58

1211

11813

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

127

1084

1.19

1.05

2.1

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

393

1.31

1.04

1.3

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

358

1.32

1.04

1.3

1.2

2.97

10.46

u/ml

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.28

1.03

1.2

1.3

1.20

1.15

mmol/l

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.64

1.03

1.6

1.4

—

(3028300) Cannabinoids [Presence] in Urine

393

0.71

1.03

3.1

1.9

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.74

1.02

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

391

0.71

1.00

3.0

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.77

1.00

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

1.62

1.00

1.1

—

72.03

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.62

1.00

1.2

1.1

—

(3022621) pH of Urine by Test strip

132

1137

1.17

0.99

3.1

2.9

6.18

6.10

0.50

103

793

(3008536) Aspergillus sp Ab [Presence] in Serum

1.95

0.97

3.4

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

100

1.61

0.96

1.2

1.1

—

(4034850) Laboratory test

443

1.27

0.96

23.8

11.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.65

0.94

3.4

3.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

418

0.74

0.92

1.6

1.8

46.45

41.13

nmol/l

0.59

399

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

171

0.58

0.91

1.6

1.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

349

1.30

0.91

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

349

1.30

0.91

1.3

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

110

1.55

0.90

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

193

1.41

0.90

1.7

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

177

1.42

0.88

1.0

1.1

1.43

2.14

eliau/ml

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

211

1.38

0.88

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

194

1.40

0.88

1.7

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

119

1.52

0.88

1.2

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.65

0.88

1.1

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

103

1.56

0.87

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

103

1.56

0.87

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

103

1.56

0.87

1.8

2.4

8.05

6.65

mmol/l

0.72

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

136

1.48

0.86

1.4

1.3

—

(40768804) Tissue Pathology biopsy report

578

5473

1.08

0.86

2.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

195

1.39

0.86

1.7

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

215

0.65

0.84

1.2

1.6

98.22

60.22

ug/l

—

185

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

203

0.64

0.84

1.2

1.5

—

(4024509) Urine culture

671

1.20

0.84

2.2

2.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

154

1.43

0.83

1.5

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

498

1.23

0.83

1.3

1.4

29.43

25.45

iu/l

0.38

422

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.70

0.82

1.1

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

330

0.72

0.82

1.8

1.9

189.42

211.09

pmol/l

0.76

311

(3042111) Morphology [Interpretation] in Bone marrow Narrative

258

1.32

0.81

1.9

1.7

—

(3024263) Appearance of Synovial fluid

1.61

0.81

1.5

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

215

1.35

0.80

2.0

5.6

279.17

353.68

umol/l

2.32

193

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

122

1.48

0.80

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

833

1.17

0.79

1.1

1.2

146.80

144.95

u/ml

0.01

316

(3022689) Creatine [Moles/volume] in Urine

1.82

0.79

1.3

1.4

6.20

7.90

mmol/l

—

(3025130) Human papilloma virus identified in Specimen

151

0.59

0.78

3.1

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

126

0.55

0.77

1.3

1.6

60.09

52.76

ug/l

—

126

(3002079) Sodium [Moles/time] in 24 hour Urine

1.70

0.75

1.1

1.4

177.22

177.62

mmol/24h

—

(4035726) Immunohistochemistry procedure

139

1235

1.14

0.73

1.5

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.64

0.73

1.7

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.64

0.73

1.7

2.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

572

5448

1.07

0.73

2.4

1.9

1.33

mmol/l

0.05

478

4581

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

125

1.44

0.72

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.80

0.72

1.3

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.58

0.71

1.5

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.58

0.71

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.58

0.71

1.5

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.58

0.71

1.5

1.9

—

(3034426) Prothrombin time (PT)

1.75

0.71

1.0

1.4

26.00

28.62

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.58

0.71

1.7

2.0

—

(44790047) Parainfluenza type 1 nucleic acid detection

203

1.34

0.71

1.6

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

203

1.34

0.71

1.6

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

203

1.34

0.71

1.6

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

203

1.34

0.71

1.6

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

143

1.40

0.70

1.5

1.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

142

0.63

0.69

1.6

1.4

14.09

24.30

u/l

—

119

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.60

0.68

1.6

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.60

0.68

1.6

1.3

—

(3003694) ABO and Rh group [Type] in Blood

406

3828

1.08

0.67

1.5

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

348

1.24

0.66

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

1.49

0.66

2.4

2.9

44.44

37.69

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.49

0.66

2.0

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.49

0.66

2.0

1.6

—

(3018133) Calcium [Moles/volume] in Urine

1.79

0.66

1.6

2.2

2.48

3.77

mmol/l

—

(4133840) Spirometry

1.79

0.66

1.0

1.1

—

(40768443) Skin Pathology biopsy report

643

1.17

0.65

1.3

1.2

—

(40768441) Liver Pathology biopsy report

103

1.46

0.65

1.2

1.5

—

(3006270) Folate [Moles/volume] in Blood

120

1.42

0.64

1.2

460.25

368.16

nmol/l

0.79

104

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

152

0.66

0.61

1.9

1.8

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.60

0.0

1.0

—

17.25

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

105

1.43

0.60

1.5

1.3

7.89

9.10

mmol/l

0.58

100

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.59

0.0

1.3

—

67.23

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.59

0.0

1.3

—

(40768800) Prostate Pathology biopsy report

355

0.79

0.59

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.45

0.59

1.1

1.2

—

(3023419) Bacteria identified in Sputum by Culture

210

1.29

0.59

1.9

2.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.58

0.0

1.3

—

26.95

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

595

1.17

0.58

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

567

5439

1.06

0.58

5.4

5.7

2.83

3.97

ug/l

0.69

509

4880

(3004616) Nuclear Ab [Presence] in Serum

158

1.33

0.57

1.2

—

(1002224) Polysomnography panel

560

0.83

0.57

1.1

—

(3019225) pH of Specimen

157

1434

1.10

0.55

7.7

4.3

7.37

7.36

0.27

120

1041

(3043238) Trisomy 21 risk [Likelihood] in Fetus

171

0.70

0.54

1.2

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

303

3213

0.93

0.53

3.3

3.4

0.87

0.80

ug/l

0.43

217

2178

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

168

1544

1.10

0.53

1.4

1.8

1.60

1.52

0.57

147

1321

(3038177) Helicobacter pylori Ab [Presence] in Serum

179

1.29

0.51

1.2

—

(40768793) Breast Pathology biopsy report

303

0.79

0.51

1.4

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.46

0.50

1.3

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.56

0.49

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

109

0.64

0.48

1.0

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

1.45

0.48

1.1

1.2

149.18

141.69

nmol/l

0.19

(3047352) Trisomy 18 risk [Likelihood] in Fetus

166

0.72

0.48

1.2

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.43

0.46

1.3

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

214

2005

1.08

0.45

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

164

0.73

0.45

1.2

1.5

1.29

—

122

(1001926) Buprenorphine [Presence] in Urine by Screen method

308

0.81

0.45

2.7

1.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

148

1.29

0.43

1.4

1.3

4998.64

160312.05

e6/l

1.38

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.43

0.42

1.1

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

102

1119

0.91

0.42

1.5

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

557

1.14

0.42

1.7

2.1

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

1.38

0.41

1.1

1.5

22.05

26.81

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.52

0.41

1.0

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.41

0.0

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

6.09

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.47

0.40

3.4

2.4

8.60

833.26

ug/l

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.33

0.40

1.3

1.7

—

1903858.33

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

141

1.28

0.40

1.1

1.46

5.73

u/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.00

0.39

0.0

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

466

1.14

0.39

1.7

2.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.37

0.38

2.3

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

216

1.21

0.37

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

189

1.22

0.36

1.8

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

189

1.22

0.36

1.8

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

460

1.13

0.36

1.6

9.15

14.19

u/ml

0.79

101

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.43

0.35

1.0

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

103

1116

0.92

0.35

1.7

2.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

190

1.21

0.34

1.8

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

234

2227

1.06

0.33

1.3

17.38

11.86

u/ml

0.43

810

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

145

1.24

0.33

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

209

0.81

0.32

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

1.31

0.32

5.1

3.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

273

0.84

0.31

3.8

2.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

208

0.82

0.31

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

1.32

0.31

2.7

1.8

0.00

estimate

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

111

1.26

0.30

1.0

1.1

308.29

284.42

mg/l

0.70

100

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

222

1.17

0.29

1.3

1.1

—

1.51

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.27

0.27

1.0

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

596

1.09

0.26

2.4

3.3

413.30

6908.22

u/ml

0.80

513

(3014133) Dog dander IgE Ab [Units/volume] in Serum

150

1.20

0.26

1.1

1.34

3.48

u/ml

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.28

0.26

2.3

2.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.30

0.26

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.68

0.26

1.0

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.28

0.24

2.7

1.4

10.50

6.60

ug/l

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.71

0.24

2.3

2.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

379

1.11

0.24

2.0

1.7

456.25

286.90

mu/l

1.08

345

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.32

0.23

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.32

0.23

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

432

0.90

0.23

2.8

3.5

0.81

nmol/l

0.01

354

(3045142) Bone marrow Pathology biopsy report

179

0.84

0.23

1.3

—

(4015189) Microbial culture of sputum

1.28

0.23

2.2

2.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

168

1610

1.05

0.21

3.3

4.2

22.48

21.04

ug/l

0.04

136

1344

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.14

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

5.3

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.12

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

5.72

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

3.12

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.21

0.0

1.4

—

6.13

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.21

0.0

1.0

—

0.06

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

135

1.19

0.21

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

135

1.19

0.21

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

135

1.19

0.21

1.4

1.7

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.21

0.0

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.05

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.20

0.19

1.2

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

174

1.15

0.19

1.1

0.73

1.58

u/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

109

1.19

0.18

1.2

0.02

1.04

u/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

428

4368

0.97

0.18

4.9

4.7

23.03

21.77

0.74

223

2230

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.19

0.18

1.1

1.0

—

(40765096) Chromosome analysis panel by Banding

1.15

0.17

1.6

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1029

0.95

0.17

1.7

2.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

183

0.87

0.16

1.0

—

(3000492) Spirometry study

124

1290

0.96

0.16

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.11

0.15

2.6

3.9

0.56

1.22

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.11

0.15

1.0

1.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

104

1084

0.96

0.15

1.6

1.5

—

(36660697) Celiac disease serology panel - Serum

110

1059

1.04

0.13

1.2

—

(40768795) Lymph node Pathology biopsy report

128

0.86

0.13

1.5

1.1

—

(4281824) Cell count and differential, peritoneal fluid

138

0.87

0.13

1.8

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

114

1.14

0.11

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

183

1.09

0.10

1.1

1.0

4.68

4.50

u/ml

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

900

0.96

0.10

1.2

—

(3044007) Cell count panel - Peritoneal fluid

1.14

0.10

4.8

1.8

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

1.09

0.09

1.8

1.3

17.06

14.16

g/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.09

0.09

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

176

0.91

0.09

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.04

0.09

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

626

1.04

0.09

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

164

1607

1.02

0.08

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

214

1.08

0.08

1.1

0.53

1.68

u/ml

—

125

(3009214) Lutropin [Units/volume] in Serum or Plasma

342

1.05

0.08

1.3

1.5

17.23

9.01

u/l

1.14

273

(1761868) Lipid panel - Serum or Plasma

482

4776

1.01

0.07

4.1

3.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

599

0.97

0.06

3.3

3.2

32.23

95.29

u/ml

2.10

578

(3024891) Influenza virus A+B Ag [Presence] in Specimen

385

0.96

0.05

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

211

0.95

0.04

1.1

12.25

22.44

au/ml

—

(3032773) Endomysium IgG Ab [Titer] in Serum

131

1.07

0.03

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

558

0.99

0.01

1.7

0.26

0.35

mg/l

0.51

259

(3017446) Testosterone [Moles/volume] in Serum or Plasma

123

1237

0.99

0.00

2.0

2.3

12.28

12.96

nmol/l

0.37

106

1104

(3023511) Choriogonadotropin [Units/volume] in Urine

154

1.04

0.00

1.5

1.2

—

(3002256) Pathology report gross observation

190

1907

1.00

0.00

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

344

1.02

0.00

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.05

0.00

1.2

1.6

96.80

85.02

umol/l

—

(3005570) Glucose [Moles/volume] in Urine

161

0.99

0.00

1.7

2.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

171

0.99

0.00

3.5

3.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

189

1.01

0.00

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

351

1.00

0.00

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

224

0.98

0.00

1.3

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

348

1.01

0.00

1.2

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

103

0.97

0.00

2.1

1.5

1.62

1.13

promille

—

(3028707) Methadone [Presence] in Urine by Screen method

173

0.98

0.00

3.4

2.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

177

1.02

0.00

1.1

0.27

1.59

u/ml

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

197

1.02

0.00

2.3

28.89

23.99

mg/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

443

0.99

0.00

1.8

3.42

3.85

mg/l

0.20

344

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.00

0.00

1.2

1.5

33.93

40.42

g/l

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

183.40

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.6

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.97

-0.00

1.0

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

2.86

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

359.17

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

2.26

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.05

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.93

-0.00

6.0

1.4

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

11.6

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.5

—

4.33

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

49.11

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.0

—

7.78

—

(4038314) Semen analysis, post vasectomy

0.00

-0.00

0.0

1.1

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

-0.00

0.0

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

-0.00

0.0

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint DM_NEOVASCULAR_GLAUCOMA and mortality.

Females

Parameter	HR [95% CI]	p-value
DM_NEOVASCULAR_GLAUCOMA	1.487 [1.34, 1.65]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.06

During the follow-up period (1.1.1998 — 31.12.2019), 2304 out of 5718 females with DM_NEOVASCULAR_GLAUCOMA died.

Males

Parameter	HR [95% CI]	p-value
DM_NEOVASCULAR_GLAUCOMA	1.544 [1.37, 1.74]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 2217 out of 5865 males with DM_NEOVASCULAR_GLAUCOMA died.

Mortality risk

Mortality risk for people of age

years, who have DM_NEOVASCULAR_GLAUCOMA.

N-year risk	Females	Males
1	0.122%	0.325%
5	0.783%	1.768%
10	1.893%	4.415%
15	3.686%	8.414%
20	6.273%	14.365%

Relationships between endpoints

↥

Index endpoint: DM_NEOVASCULAR_GLAUCOMA – Neovascular glaucoma

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Neovascular glaucoma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints